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ABSTRACT
The detection and identification of disease-causing parasites via DNA and the 
polymerase chain reaction (PCR) offers a new approach for quick and efficient disease diagnosis. 
Three nucleic acid based technologies have been developed and optimized for the identification 
of six species of parasites that cause disease, and designed to amplify small fragments of DNA 
likely to remain in archaeological material. Two methods involve a species-specific 
identification by examining four gene fragments, one of which has been designed as a multiplex 
PCR to minimize the time required for diagnosis. The third method involves the use of one 
species-specific gene target per parasite in a multiplex PCR for the detection of multiple 
parasites in one reaction to expedite the testing process and confirmation of the disease in 
question in a clinical setting. Sensitivity and specificity have been proven through the use of a 
1/1000 diluted DNA template and sequencing of products confirmed the presence of each 
species analyzed. With increased sensitivity, a less invasive sampling procedure would be 
required from the patient. Also, the earlier the presence of parasites in the tissues is detected, the 
earlier the diagnosis would occur. Tissues that contain very few parasites and had been 
classified as previously unusable for diagnosis or tissues from older medical cases can be 
analyzed for the presence of disease and the identification of causative species. The successful 
application of the singleplex PCR technique to Plasmodium falciparum and Leishmania 
degraded DNA samples leads to the feasibility of success for the multiplex PCR techniques 
involving degraded DNA analyses. Therefore, this methodology may be applied to samples of 
unknown disease content to either include or exclude the agents of disease. Future directions 
may extend these analyses to include a range of other agents of disease, thus allowing for the 
determination of disease antiquity through degraded DNA analyses.
XI
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CHAPTER 1: INTRODUCTION
1
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The success of an organism or group of organisms depends on their ability to adapt and 
thrive in complex ecosystems. The parasitic way of life is highly successful because it evolved 
independently in nearly every phylum of animals, from protistan phyla to arthropods to 
chordates, as well as in many plant groups resulting in a greater abundance of parasitic 
organisms than nonparasitic organisms in the world (Roberts and Janovy Jr 2000). Parasites are 
defined as any life form -  or any organic compound capable to multiply -  that find their 
ecological niche in another living form (Araujo et al. 2003). They find in another organism their 
habitat and nourishment and during at least part of their lives depend upon another organism 
(Araujo et al. 2003).
Generally speaking, the study of the parasite-host relationship can be referred to as 
parasitology. A more common definition is a study of symbiosis, or literally, “living together”, 
or in a wider sense, any two organisms living in close association, commonly one living in or on 
the body of the other, are symbiotic, as contrasted with free-living organisms (Roberts and 
Janovy Jr 2000). However, these symbiotic relationships can be characterized further into 
phoresis, mutualism, commensalisms and parasitism by specifying the nature of the interactions 
between the participants (Roberts and Janovy Jr 2000). These various forms of symbiosis are 
defined below.
Four categories of symbiotic relationships exist: phoresis, mutualism, commensalisms 
and parasitism. Phoresis exists when two symbionts are merely “travelling together”, and there 
is no physiological or biochemical dependence on the parts of either participant (Roberts and 
Janovy Jr 2000). Mutualism describes a relationship, usually obligatory, in which both partners 
benefit from the association, and in commensalisms, one partner benefits from the association, 
but the host is neither helped nor harmed (Roberts and Janovy Jr 2000). Most attention is
2
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focused on the parasitic relationship, which causes harm to the host. In parasitism, one of the 
participants, the parasite, either harms its host or in a sense lives at the expense of the host by 
causing mechanical injury, stimulating a damaging inflammatory or immune response, or simply 
by robbing the host of nutrition (Roberts and Janovy Jr 2000). Many researchers have invested 
interest and effort in and trying to understand the mechanism and evolutionary benefit behind 
such a phenomenon.
Parasite Evolution
The evolution of parasites can be directly linked to their ability to co-exist alongside and 
within a multitude of various species and ecological niches. A system is formed by the parasite, 
the host, and the environment where each one interacts and influences the other subsystem in 
such a way that any change in one subsystem affects the other two (Araujo et al. 2003). A 
parasite may be associated with a host because the two share a long evolutionary history 
(descent), or the host and parasite may be associated because the parasite has colonized the host 
in a manner analogous to the colonization of an island (Roberts and Janovy Jr 2000). With this, 
parasite life history traits (such as fecundity), life cycles themselves (loss or addition of stages), 
and virulence are all subject to evolutionary change (Roberts and Janovy Jr 2000). However, the 
question of why some parasites seem to be especially virulent while others are relatively benign 
has captured that attention of numerous researchers since a long and established paradigm states 
that parasites should evolve into less virulent forms, mainly because death of a host should have 
a negative effect on parasite survival (Roberts and Janovy Jr 2000). Nonetheless, some theories 
have suggested that parasites should evolve an optimal virulence that maximizes parasite 
numbers, “optimal” depending on numerous factors such as pathogenicity and transmission 
dynamics (Roberts and Janovy Jr 2000). However, parasitic infections and parasitic diseases are
3
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two distinct situations since a parasite’s presence is a necessary but not sufficient condition to 
launch a parasitic disease and the resultant parasitism does not necessarily result in injury or 
benefit to the host (Araujo et al. 2003). Thus, a parasitic disease can be described as an eventual 
outcome of a given parasite in a given host from a given population in a certain environment 
during a particular life co-evolution period of both protagonists (Araujo et al. 2003). The views 
concerning parasite virulence have generated interest on finding the evolutionary trends of many 
parasite-induced diseases and constructing a timeline of parasite evolution so as to extrapolate to 
trends of today.
Paleoparasitology
The analysis of cultural and biological specimens collected from the past can reveal many 
important facets of evolutionary history and begin to create a timeline of host-parasite events. 
Many significant remnants in the genome of parasites and hosts left during the co-evolution 
process of a host-parasite-environment system are transmitted and can reveal important features 
of the whole process (Araujo et al. 2003). Thus, the term paleoparasitology (also 
archaeoparasitology) has been applied to the development of a new field, with its unique relation 
to both parasitology and anthropology (especially parasite ecology and paleopathology), and its 
derivation of specialized analytical techniques (Reinhard 1990). It first appeared as a new
a
branch of parasitology at the beginning of the 20 century, when a new technique to rehydrate 
desiccated tissues allowed the finding of Schistosoma haematobium eggs in infected kidneys of 
3,200 year-old Egyptian mummies (Ruffer 1910; Loreille and Bouchet 2003) and thus was 
defined as the study of parasites in ancient material (Araujo et al. 1998). This approach allows 
inferences about disease patterns in the past, thus contributing to the knowledge of diseases in 
prehistoric populations (Ferreira et al. 2000). It offers the unique possibility of working with
4
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ancient parasites and may shed light upon features concerning the antiquity of a given host- 
parasite complex as well as their origin and evolution (Araujo et al. 2003). Due to the 
development and application of new molecular techniques, which have allowed for the recovery 
of ancient DNA (aDNA) from archaeological material, the possibility for the study of human- 
parasite relationship through the finding of genetic traces of etiological agents of disease has 
been opened (Ferreira et al. 2000).
Polymerase Chain Reaction
The polymerase chain reaction (PCR) technique is considered by molecular analysts to 
have started an avalanche in technology and research. Originally described by Kary Mullis in 
1985 (Mullis et al. 1986) this technique, although quite an extraordinary accomplishment 
contained one major drawback, the addition of fresh enzyme to every cycle of the reaction (Saiki 
et al. 1988). However, improvements were made through numerous experiments and it was 
found that a thermostable DNA polymerase, purified from the thermophilic bacterium, Thermus 
aquaticus (Taq) (Saiki et al. 1988) alleviated this problem. Following were substantial 
improvements of the overall performance, yield, sensitivity and length of targets that could be 
amplified (Saiki et al. 1988). These made possible the capacity to amplify specific segments of 
DNA and have transformed the way we think about approaching both fundamental and applied 
biological problems (Erlich 1989). PCR has provided an extremely sensitive and relatively 
straightforward means to amplify very small amounts of DNA or RNA -  down to a single copy 
of a gene, to milligram amounts of the same sequences consisting of millions or billions of 
identical copies for detection, sequencing, cloning, diagnosis, etc. (Saiki et al. 1988). Before its 
introduction, DNA amplification could only be achieved by time-consuming in vivo cloning that
5
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
took several day, and now PCR can be set up and completed in a matter of hours (Saiki et al. 
1988).
Methodology
PCR is an in vitro method for the enzymatic synthesis of DNA sequences, using two 
oligonucleotide primers that hybridize to opposite strands and flank the region of interest in the 
target DNA (Mullis et al. 1986; Erlich 1989). Reduced to its most basic terms, PCR merely 
involves combining a DNA sample with oligonucleotide primers, deoxynucleotide triphosphates 
(dNTPs), and the thermostable Taq DNA polymerase in a suitable buffer, then repetitively 
heating and cooling the mixture for several hours until the desired amount of amplification is 
achieved (Saiki et al. 1988; Erlich 1989). However, the reaction itself is based on three steps: 
denaturation, annealing and elongation phases, all of which are repeatedly in sequence, a process 
known as “cycling” (Saiki et al. 1988; Hummel 2003).
Initially, in the denaturation phase, the double-stranded DNA molecules denature into 
single strands through a high energy input that force open the hydrogen bonds between the 
complementary bases (Saiki et al. 1988; Hummel 2003). Following this, an annealing phase 
occurs, which enables the primers or oligonucleotides to hybridize to their recognition sites at 
temperatures dependent on the actual primer sequence (Saiki et al. 1988; Hummel 2003). The 
final elongation phase is where a heat-stable DNA polymerase begins to incorporate the 
complementary deoxynucleotide triphosphate bases starting from the 3'-end of the primers (Saiki 
et al. 1988; Hummel 2003) and results in the accumulation of a specific fragment whose termini 
are defined by the 5'-ends of the primers (Mullis et al. 1986; Erlich 1989). The repetitive nature 
of the technique (“cycling”) thus enables newly synthesized primer extension products them to
6
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serve as a template, resulting in an exponential increase, i.e. approximately doubling of the 
number of target DNA copies with each cycle (Mullis et al. 1986; Erlich 1989).
With these basic methodological steps involved in the PCR technique, it must be 
understood that there is no single set of conditions that will be optimal for all possible reactions 
(Erlich 1989). For example, the annealing and separation of the two strands depend on a number 
of factors, particularly temperature, salt concentration, pH, nucleotide composition and length of 
the sequence concerned (Saiki et al. 1988). However, considered to be of utmost importance is 
the DNA template itself. With improved molecular techniques arising, expanding the quantity 
and quality of genomic template analyzed, one fundamental concern involves understanding the 
mechanisms involved in the degradation process of DNA and how to overcome such an 
inhibiting factor.
Primer Design
The design and implementation of primers is one of the most important procedures for a 
specific and high quality PCR reaction. The primer sequences determine which particular 
sequence of a genome will be targeted in a PCR experiment and the specificity of the reaction is 
ensured when the primer sequences are a complete match with the intended hybridization site 
and are unique within the genome in focus (Saiki et al. 1988; Hummel 2003). In addition, the 
length of the primer and the annealing temperature of the PCR control the specificity 
(Dieffenbach et al. 1993).
The initial step in primer design begins with the length of the sequence required. 
Oligonucleotides between 18 and 30 bases (Erlich 1989; Dieffenbach et al. 1993) tend to be very 
sequence specific if  the annealing temperature of the PCR is set within a few degrees of the
7
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primer Tm (defined as the dissociation temperature of the primer/template duplex) (Dieffenbach 
et al. 1993). However, with a few simple guidelines, primers can be optimally designed.
1. Where possible, select primers with a random base distribution and with a GC content 
similar to that of the fragment being amplified (Erlich 1989). However, the length of the 
PCR product has an impact on the efficiency of amplification (Dieffenbach et al. 1993).
2. Avoid sequences with the potential for significant secondary structure, particularly at the 
3'-end of the primer (Erlich 1989).
3. Check the primers against each other for complementarity (Erlich 1989). This is done to 
avoid the undesirable primer-dimer phenomena in which the PCR product obtained is the 
result of the amplification of the primers themselves (Dieffenbach et al. 1993).
If the guidelines have been followed, the specificity of the reaction will be greatly enhanced. 
However, altering PCR parameters for increased PCR optimization is also required. This 
requires an empirical approach to determine the correct concentration of reagents and optimal 
temperature for each PCR. Nonetheless, if the PCR is optimally designed, problems do still exist 
in the form of contaminating DNA. Therefore, researchers have imposed certain requirements 
for contamination control.
Multiplex PCR
Multiplex PCR is a variant of PCR in which two or more loci are simultaneously 
amplified in the same reaction. Since its first description in 1988, this method has been 
successfully applied in many areas of DNA testing, including analyses of deletions, mutations 
and polymorphisms, or quantitative assays and reverse transcription (Chamberlain et al. 1988; 
Henegariu et al. 1997). A short list of multiplex PCR applications now includes pathogen 
identification, gender screening, linkage analysis, forensic identification, template quantitation
8
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and gender disease diagnosis (Edwards and Gibbs 1994). By simultaneously amplifying more 
than one locus in the same reaction, multiplex PCR is becoming a rapid and convenient 
screening assay in both the clinical and the research laboratory (Henegariu et al. 1997).
In multiplex assays, where closely related templates such as pathogen strains are 
distinguished by amplifying differing sequence, primers for a sequence common to all templates 
provide a positive control for amplification (Edwards and Gibbs 1994). The quality of the 
template may be determined more effectively in multiplex than in single locus PCR and the 
expense of reagents and preparation time is less in multiplex PCR than in systems where several 
tubes of singleplex PCRs are used (Edwards and Gibbs 1994). Consequently, a multiplex 
reaction is ideal for conserving costly polymerase and template in short supply (Edwards and 
Gibbs 1994). Therefore, for maximum efficiency of preparation time, the reactions can be 
prepared in bulk, randomly tested for quality, and stored frozen without enzyme or template until 
use (Edwards and Gibbs 1994).
Critical Components
There are certain unique components to take into account when designing a multiplex 
PCR. Multiplex PCR requires that primers lead to amplification of unique regions of DNA, both 
in individual pairs and in combinations of many primers, under a single set of reaction conditions 
(Markoulatos et al. 2003). The development of an efficient multiplex PCR usually requires 
strategic planning and multiple attempts to optimize the reaction conditions (Markoulatos et al. 
2003). Thus, there are some important factors to consider.
Primer Concentration
The primer concentration is a significant constituent. When there is uneven 
amplification, with some of the products barely visible even after the reaction was optimized for
9
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the cycling conditions, changing the proportions of various primers in the reaction is required, 
with an increase in the amount of primers for the “weak” loci and a decrease in the amount for 
the “strong” loci (Markoulatos et al. 2002). The final concentration of the primers (0.04- 
0.05|iM) may vary considerably among the loci and is established empirically (Markoulatos et 
al. 2002).
dNTP Concentration
The amount of dNTPs added to a PCR is important for reliable unhindered amplification. 
Their role falls within the elongation phase of PCR, where the Taq DNA polymerase 
incorporates these nucleotides, thus extending the primers and producing two copies of the 
original target strands (Saiki et al. 1988; Markoulatas et al. 2003). Usually MgCh concentration 
is kept constant, while the dNTP concentration is increased stepwise from 0.5-1.6mM 
(Markoulatos et al. 2002). However, the best results are between 200 and 4Q0fiM each dNTP 
values, above which the amplification is rapidly inhibited (Markoulatos et al. 2002).
MgCh Concentration
The addition of MgCh to a PCR contributes to the Mg2+ which must be optimized. 
Optimization of Mg2+ is critical since Taq DNA polymerase is a magnesium-dependent enzyme, 
and the template DNA primers and dNTPs bind Mg2+ (Markoulatos et al. 2002). Excessive Mg2+ 
concentration stabilizes the DNA double strand and prevents complete denaturation of DNA, 
which reduces yield and can also stabilize spurious annealing of primer to incorrect template
A I
sites (Markoulatos et al. 2002). On the other hand, inadequate Mg concentration reduces the 
amount of product (Markoulatos et al. 2002).
10
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PCR Buffer Concentration
The specific DNA polymerase buffer is also a critical reagent. Raising the buffer 
concentration improves the efficiency of the multiplex reaction (Markoulatos et al. 2002).
Primer pairs with longer amplification products work better at lower salt concentrations, whereas 
primer pairs with short amplification products work better at higher salt concentrations 
(Markoulatos et al. 2002).
Use of Adjuvants
The most difficult multiplex PCR reactions can be significantly improved by using a PCR 
additive, such as dimethyl sulfoxide (DMSO), glycerol, formamide, betaine and bovine serum 
albumin (BSA), which relax DNA, thus making template denaturation easier (Markoulatos et al. 
2002).
Contamination Sources and Control
Researchers utilizing the PCR technique, have to contend with the possibility of 
experimental contamination from extraneous DNA, such as bacterial, atmospheric or human. 
Many precautions must them be taken to avoid such contamination from sources such as these. 
Thus, a few sources of contamination and the requirements of control and prevention are 
presented.
One source of contamination is referred to as carry-over contamination. This occurs if  
amplification products are introduced to a pre-PCR analysis step (Handt et al. 1994; Hummel 
2003), such as the air movement produced when opening PCR tubes or transferring liquids will 
create and disperse microscopic aerosol droplets, which can contain over a million copies of the 
template (Willerslev and Cooper 2005). A second source of contamination, referred to as cross­
contamination, occurs as a result of sample-to-sample contamination (Hummel 2003), which can
11
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be present in the specimens before samples are removed (Handt et al. 1994), and a third source, 
but not the last, is contamination via chemicals; the reagents used in the PCR (Hummel 2003).
In order to minimize the risk, complete physical separation of pre- and post-PCR work spaces is 
necessary; technique devices should never be exchanged between these areas (Montiel et al. 
2001). Regular controls without the addition of a template are suitable to monitor 
contaminations of the carry-over type (Handt et al. 1994; Hummel 2003), and most important, it 
is required that all PCR analysis steps, starting with sample preparation, DNA extraction and 
PCR set-up, following through to the end of the experiment, should be done with careful 
consideration (Hummel 2003).
The requirements of contamination control are basically the same at all stages of the PCR 
analysis (Hummel 2003). Strict separation for the handling of the samples, effective cleaning 
management for all equipment that is in direct contact with the samples, changing disposable 
gloves when handling different samples is required (Hummel 2003). Under no circumstances 
should touching of the inner surfaces of the reaction tubes occur, precise pipetting and finally, 
the use of positive displacement pipettes or aerosol-tight pipette tips are a necessity (Hummel 
2003). If all precautions have been taken, the risk of contamination will be minimized.
However, there are a few monitoring techniques implemented for PCR that may indicate the 
presence of contamination.
Contamination is a big problem when working with the PCR technique. Many 
researchers have thus used stringent controls to test the reaction for the possibility of 
contamination such as, the use of a blind control. This product undergoes all the extraction, 
purification and amplification procedures, except that it does not contain any sample material 
(Herrmann and Hummel 1994). This type of control will reveal even minor contaminations in
12
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any of the reagents and chemicals used in the procedures (Herrmann and Hummel 1994). A 
second type of control is no-template control. This control serves only for the amplification 
reagents and conditions; it contains every amplification reagent except the DNA template 
(Herrmann and Hummel 1994). The inclusion of the aforementioned controls as well as other 
more research-specific requirements is of great importance to PCR research. Therefore, all 
reactions should implement them in the research as a form of authenticity of results.
DNA Degradation
A serious concern pertinent to the study of aDNA is the occurrence of postmortem 
damage in DNA extracted from archaeological material, since such damage may make 
impossible the application of many molecular biological techniques and/or cause erroneous 
sequence information to be obtained (Paabo 1989). The likely reason for this is damage to the 
DNA that occurs over time and eventually renders the DNA unable to serve as a template for 
PCR (Hoss et al. 1996). This damage may arise from environmental exposures such as low-level 
radiation or genotoxic chemicals (DNA damaging agents) or can be introduced during DNA 
extraction and/or purification processes (Mitchell et al. 2005). Therefore, overcoming the 
obstacles presented by postmortem DNA damage is a priority.
When an organism dies, the DNA molecules face an onslaught of destructive processes 
which put at risk its integrity. Firstly, bacteria, fungi and insects may be present at the site of 
organism decomposition and accelerate DNA damage by feeding on and degrading 
macromolecules (Paabo et al. 2004). Alternatively, or in conjunction with these organisms, 
cellular compartments within the decaying organism that normally sequester catabolic enzymes 
break down and the DNA is rapidly degraded by enzymes such as lysosomal nucleases (Paabo et 
al. 2004). Although, under fortunate circumstances, such as rapid desiccation, low temperatures
13
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or high salt concentration, nucleases themselves become destroyed or inactivated before all 
nucleic acids are reduced to mononucleotides (Hofreiter et al. 2001).
Damage to DNA extracted from archaeological remains is exhibited by the nature of 
fragment size available for molecular analyses. On average, smaller fragmented DNA has a 
general size between 100 to 500 base pairs (bp) due to both enzymatic processes that occur 
shortly after death, and nonenzymatic hydrolytic cleavage (Paabo et al. 2004). Due to its 
hydrophilicity, DNA remains hydrated even in dry climates and hydrolytic damage will occur 
(Handt et al. 1994) such as cleavage of phosphodiester bonds in the phosphate-sugar backbone 
that generate single-stranded nicks and/or hydrolytic cleavage of the glycosidic bonds between 
nitrous bases and the sugar backbone resulting in abasic sites (Figure 1) (Paabo et al. 2004).
DNA sequence amplification is also limited by lesions induced by free radicals such as 
peroxide radicals (*0 2 ), hydrogen peroxide (H2O2), and hydroxy radicals (•OH), which are 
created by among other causes, background radiation (Paabo et al. 2004). Major sites of 
oxidative attack are the double bond of both pyrimidines and purines (Paabo et al. 2004), which 
may lead to high proportion of cytosine and thymine residues in extracts of ancient tissues that 
are oxidatively modified to hydantions (oxidative products of the pyrimidine bases cytosine and 
thymine), which block DNA polymerases and thus the PCR (Hofreiter et al. 2001).
DNA polymerases may also be hindered in function by cross-link damage in DNA 
(Paabo et al. 2004). Examples of such a phenomenon are referred to as Maillard products. 
Maillard products are formed by condensation reactions between sugars and primary amino- 
groups in proteins and nucleic acids, but can be broken by treatment with N-phenacylthiazolium 
bromide allowing for DNA sequence amplification from some ancient remains (Paabo et al. 
2004; Vasan et al. 1996).
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Figure 1. Post-mortem DNA modification in fossil remains, with the structures altered by damage shown in 
red (Willerslev and Cooper 2005). (a) Formation of strand breaks (single-stranded nicks) by hydrolytic damage, 
(i) Direct cleavage of the phosphodiester backbone (A), (ii) Depurination resulting in a baseless site (AP-site) (B) 
followed by breakage of the sugar backbone through p-elimination (C). Strand breaks are believed to be largely 
responsible for the short amplification length and the high rate of DNA loss in fossil remains, (b) Different types of 
crosslink formation, (i) Inter-strand crosslinks by alkylation. (ii) Intermolecular crosslinks by Maillard reaction. 
Crosslinks may prevent the amplification of endogenous template molecules, increasing the risk of contamination, 
(c) Oxidative and hydrolytic modification of bases resulting in (i) blocking lesions or (ii) miscoding lesions. Some 
oxidative damage results in lesions blocking the polymerase enzyme, and promoting chimeric sequences through 
‘jumping PCR’. Hydrolytic damage of bases may result in miscoding lesions, for exampled, deamination of 
cytosine and adenine to uracil and hypoxathine, respectively. These lesions will result in the incorporation of 
erroneous bases during amplification (Willerslev and Cooper 2005).
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Modifications to DNA sequences by other known and unknown types of damage are 
common and problematic in aDNA analyses (Handt et al. 1994). Most common are hydrolytic 
loss of amino groups, from the bases adenine, cytosine, 5-methylcytosine, and guanine resulting 
in hypoxanthine, uracil, thymine, and xanthine respectively (Poinar 2003). The deamination 
products o f cytosine (uracil) and of 5-methylcytosine (thymine) are of particular relevance for 
the amplification of ancient DNA since they cause incorrect bases (A instead of G, and C instead 
of T) to be inserted when new DNA strands are synthesized by a DNA polymerase (Handt et al. 
1994). As time passes, the cumulative effects of damage to the DNA will be so extensive that no 
useful molecules remain (Hofreiter et al. 2001).
Authenticity of Degraded and Ancient DNA
Post-mortem DNA stability and survival is dependent on numerous circumstances that 
differ between all samples analyzed. However, in general, researchers have to contend with the 
fact that very little and often no DNA survives in ancient tissue (Hofreiter et al. 2001), thus in 
order to utilize PCR as a detection method for DNA in archaeological specimens, certain 
alterations of the protocol must be done. Usually PCR cycle number must be increased to ensure 
amplification of the degraded DNA, and because the DNA is degraded, primers must be 
designed to amplify DNA fragments with a maximum length of 300 base pairs (bp). Knowledge 
of the pervasive nature of contamination in aDNA technology has enhanced our ability to detect 
contamination, permitting a high degree of confidence when analyzing ancient, nonhuman 
organisms (Kolman et al. 1999). This usually low amount of authentic DNA in samples o f up to 
several thousand years of age significantly increases the susceptibility of the PCR technique to 
contamination with modem DNA (Zink et al. 2002), due to its pervasiveness in the environment, 
both inside and outside of the laboratory (Hofreiter et al. 2001). Thus, the inclusion of a positive
16
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PCR control of DNA extracted from modem specimens can inadvertently contaminate the 
archaeological specimen and provide template for the PCR even when DNA is stored separately 
from aDNA samples (Kolman et al. 1999). Therefore, strict precautions to avoid contamination 
with extraneous DNA in PCR have been imposed (Hofreiter et al. 2001), and there exists a 
general consensus on the clear necessity of strictly controlled conditions by all researchers 
working with aDNA (Zink et al. 2002). For example, the extraction and preparation of the PCR 
must be done in a laboratory that is rigorously separated from the work involving modem DNA 
(Hofreiter et al. 2001). Treatment of the laboratory equipment with bleach, UV irradiation of the 
entire facility, protective clothing and face shields are other routine precautions (Hofreiter et al. 
2001). In addition, several criteria of authenticity are essential for believing that DNA sequences 
are ancient (Figure 2). Even when all precautions are followed perfectly, contamination may still 
occur, if for no other reasons than because the specimens themselves may be contaminated with 
modem DNA (Hofreiter et al. 2001).
17
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Physically isolated work area
To avoid contamination, it is essential that all DNA work be carried out in an isolated lab dedicated to low copy number samples. 
A  separate building, if  possible where no genetic work is being carried out, would be the best possible situation. Post-DNA 
extraction, all PCR reactions can be set up in this laboratory space and then moved to a normal lab for subsequent typing and 
sequencing.
Extraction controls and PCR product
M ock extractions and PCRs without template DNA are elementary controls that should be carried out.
Decontamination o f  reagents and specimens
Bleach, acid, ultra-filtration, baking and UV irradiation o f reagents and tools should be routine; particularly important in ancient 
human and microbial studies. The surface o f samples should be removed.
Uracil-N-glycosylase (UNO) treatment
UNG removes deamination products o f cytosine, and is particularly important in studies where results involve few substitution 
differences.
Inverse correlation between amplicon length and amplification efficiency 
Generally, amplification of only short DNA pieces is possible.
Quantitation o f  numbers o f  template molecules
I f  the number o f DNA molecules that initiate the PCR is less than ~1,000, at least three independent amplifications need to be 
analyzed, and the products need to be cloned and several clones should be sequenced.
Exclusion o f  nuclear insertions o f  mitochondrial DNA
Pieces o f mitochondrial DNA (mtDNA) exist in the nuclear genome and represent a potential source o f false results. Sometimes, 
they can be detected by the observation o f  several mtDNA sequences from an extract, or by finding the same sequence in another 
closely related species. I f  overlapping amplifications using different primers detect the same sequence over an area that is highly 
variable, it is unlikely that the sequence derives from a nuclear insertion.
Time-dependent pattern o f damage and diversity 
Provides strong support for antiquity in microbial studies.
Biochemical assay fo r  macromolecular preservation
Amino-acid analysis should show that the state o f preservation o f the specimen is compatible with DNA preservation. 
Amplification from a second extract
The reproduction o f the results from a second, independent extract should show that the result is reliable.
Clone
Direct sequencing o f PCR products should be verified by cloning amplified products and sequencing ten clones to determine the 
ratio o f  endogenous to exogenous sequences, and damaged induced errors.
Reproduction in a second laboratory
W hen a new or unexpected result is obtained, reproduction in a second laboratory, preferably from a sample that has been 
independently sent from the museum to the second laboratory, ensures that the laboratory-specific contamination is not the source 
o f the sequence determined.
Associated remains
In studies o f human remains where contamination is especially problematic, evidence that DNA targets survive in associated 
faunal material can provide critical supporting evidence.
Phylogenetic sense
Reproducible sequences should in the end be placed in a tree phylogenetically with other known haplotypes in order to ensure 
that as the final criteria they are indeed authentic. This approach is particularly important in the case o f detecting mitochondrial 
pseudogenes in the nucleus.
Figure 2. Authenticity criteria to determine ancient DNA sequences (Hofreiter et al, 2001; Poinar 2003; 
Willerslev and Cooper 2005).
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CHAPTER 2: PARASITES INVOLVED IN HUMAN DISEASE
19
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Malaria
There are fours species of Plasmodium that cause human malaria. These protozoan 
parasites are concentrated in the sub-Saharan Africa, and have been estimated by the World 
Health Organization to cause 300 to 500 clinical cases per year, with more than two billion 
people at risk throughout the world, with Plasmodium falciparum being the most fatal version of 
the disease (Rich and Ayala 2000). Utilizing two species of mosquitoes as the host transport, 
Anopheles gambiae and Anopheles funestus, P. falciparum infection has greatly expanded due to 
stagnant pools of water for breeding and an increase in mosquito-human contact (McElroy and 
Townsend 1989).
Biology
When residing in mosquitoes, Plasmodium species are associated with the insect’s gut 
and salivary glands. Transmission to humans occurs within an initial bite and transfer of saliva 
of an infected mosquito to a human host. This feeding allows for the introduction of the parasite 
in sporozoite form where they travel to the liver, develop into merozoites, and then invade and 
multiply the red blood cells via the trophozoite stage (Wirth 2002). The merozoites in s subset of 
infected red blood cells then develop into gametocytes (Wirth 2002). The cycle continues when 
another mosquito bites the infected host, taking up the gametocytes, which develop into male and 
female reproductive cells (gametes) (Wirth 2002). These fiise in the insect’s gut to form a 
zygote, which in turn develops into the ookinete, crosses the wall of the gut and forms 
sporozoites-filled oocyst (Wirth 2002). The oocyst eventually bursts, releasing the sporozoites 
that move to the mosquito’s salivary glands, and once this mosquito feeds on a host, the process 
begins again (Figure 3) (Wirth 2002).
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Figure 3. Life cycle of Plasmodium falciparum (Wirth 2002).
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Pathogenesis
Most of the major clinical manifestations of malaria may be attributed to two general 
factors: (1) the host inflammatory response, which produces characteristic chills and fever, and 
(2) anemia, arising from enormous destruction of red blood cells (Roberts and Janovy Jr 2000). 
When the protozoa destroy the cells, usually at two or three-day intervals, the release of waste 
products and pigment brings on severe intermittent bouts of chills and fever (McElroy and 
Townsend 1989). The destruction of red blood cells during the erythrocytic cycle usually leads 
to anemia, which may be compounded by other immunopathological mechanisms (Taylor et al. 
1997). The anemia caused by malaria is a serious hazard in pregnancy, and infection of the 
placenta by malaria parasites causes low birth weight in infants and in some cases miscarriage 
and stillbirth (McElroy and Townsend 1989). The most severe of the four species, P. falciparum 
causes acute symptoms in victims, especially among small children (McElroy and Townsend 
1989).
Plasmodium falciparum is a cause of the more serious ‘cerebral’ malaria with continuous 
fever and jaundice, which can prove rapidly fatal (Taylor et al. 1997). Blackwater fever is an 
acute, massive lysis of erythrocytes, marked by high levels of free and breakdown products of 
hemoglobin in blood and urine, and by renal insufficiency (Roberts and Janovy Jr 2000). A 
combination of other severe manifestations leads to a condition known as algid malaria, which is 
the rapid development of shock and may be associated with septicemia, with toxemia and 
massive gastrointestinal hemorrhage (Roberts and Janovy Jr 2000).
Diagnoses
Diagnosis of this agent of disease may, to some extent, depend on the clinical 
manifestations of the disease itself, but the demonstration of the parasite in stained smears of
22
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peripheral blood is most important (Roberts and Janovy Jr 2000). However, with microscopic 
identification, staining of the sample is critical for successful identification as well as timing of 
blood examination because, depending on the stage of the parasite’s developmental cycle at 
which the blood sample is taken, various stages of the parasite will appear (Markell et al. 1992). 
An improved immunological method has also been employed with great success. It is referred to 
as the dipstick method, in which detection of a P. falciparum antigen in the blood of infected 
individuals provides a positive identification (Roberts and Janovy Jr 2000).
Schistosomiasis
Schistosomiasis is the general recognized term for a disease caused by species within the 
genus Schistosoma. Schistosoma haematobium is one member of the species producing the 
human disease urinary schistosomiasis (Markell et al. 1992). Originally, this disease apparently 
focused along the Nile Valley, where it is highly endemic (Markell et al. 1992). From there, this 
disease spread throughout Africa and Turkey (Markell et al. 1992).
Biology
This species, along with other members are dioecious with a male and female 
permanently paired throughout life (Ruppert and Barnes 1994) and adult worms inhabiting the 
veins that drain organs of their host’s abdomen (Roberts and Janovy Jr 2000). Females usually 
reside in the gynecophoral canal of the males (Roberts and Janovy Jr 2000) but leave the males 
to deposit their eggs in small venules close to the lumen of the bladder (Markell et al. 1992). 
Then, the eggs must traverse the wall of the venule, some intervening tissue, and the bladder 
mucosa before they are in position to be expelled from the host (Roberts and Janovy Jr 2000) by 
means of an enzyme elaborated by the miracidium which diffuses through the egg shell and 
helps to digest the overlying tissue, or with some speculation, small spines on the eggs (Markell
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et al. 1992). By the time the eggs are excreted with the urine of the host, they are completely 
embryonated and hatch when exposed to the lower osmolarity of fresh water (Roberts and 
Janovy Jr 2000) and the miracidium escapes. The miracidia are well supplied with sensory 
receptors and seek out particular species of freshwater snail; species of Bulinus and Physopsis, 
and possibly Planorbarius (Roberts and Janovy Jr 2000). If successful, the miracidium 
penetrates the snail, where it undergoes a cycle of development, giving rise to a large number of 
cercariae infective for humans (Markell et al. 1992).
The cercariae start to emerge from the snail host about four weeks after initial penetration 
by the miracidium (Roberts and Janovy Jr 2000). Once in contact with human skin, they attach 
and penetrate using enzymes and muscular boring movements (Ruppert and Barnes 1994). The 
now tailless “schistosomules” are carried to the bloodstream first to the lungs, then to the liver 
(Ruppert and Barnes 1994) where they mature in the sinusoids and migrate to reach the vesical, 
prostatic and uterine plexuses by way of the hemorrhoidal veins (Markell et al. 1992). The cycle 
then begins again when eggs are deposited in the walls of the bladder where they eventually 
break through into the lumen and escape with the urine (Figure 4).
Pathogenesis
Schistosomiasis is a debilitating disease and can be lethal (Ruppert and Barnes 1994). 
Pathogenesis is almost entirely due to the eggs and not to the adult worms (Roberts and Janovy 
Jr 2000). Egg penetration through the intestinal wall and bladder, aberrant lodging of eggs in 
various organs, and the developmental stages in the lung and liver can result in inflammation, 
necrosis or fibrosis, depending on the degree of infection (Ruppert and Barnes 1994). However, 
schistosomiasis is usually divided into three pathological phases: migratory, acute and chronic.
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Figure 4. Life cycle of Schistosoma haematobium (modified) (Roberts and Janovy Jr 2000).
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The migratory phase encompasses the time from penetration until maturity and egg 
production (Roberts and Janovy Jr 2000). Following cercariae penetration of the skin, transient 
toxic and allergic manifestations may occur, which may be very mild or even passed as 
unnoticed (Markell et al. 1992). Soon after, the developing schistosomes reach the liver and 
acute hepatitis may develop (Markell et al. 1992).
The acute phase, also known as katayama fever, occurs when schistosomes begin 
producing eggs about four to six weeks after initial infection (Roberts and Janovy Jr 2000). The 
host has considerable exposure to various schistosome antigens causing a change in the antigen- 
antibody ratio, which leads to the formation of large immune complexes marked by chill and 
fever, fatigue, headache, malaise, muscle aches, lymphadenopathy, and gastrointestinal 
discomfort (Roberts and Janovy Jr 2000). Granulomas surrounding the eggs may become 
fibrous or pseudotubercles, so called because of their resemblance to localized nodules of tissue 
reaction (tubercles) in tuberculosis (Roberts and Janovy Jr 2000). Many eggs however, may be 
carried by the hepatic portal circulation into the liver, lungs or other tissues where granuloma 
formation may be stimulated (Roberts and Janovy Jr 2000).
The chronic stage of the disease comes on gradually (Markell et al. 1992). Egg 
deposition in the smaller venules close to the lumen of the intestine or bladder may evoke the 
formation of minute abscesses, however, eggs that become dislodged and swept into circulation 
produce the most pathologic changes (Markell et al. 1992). Although this stage is commonly 
asymptomatic with S. haematobium infection, there may be pain on urination and blood in the 
urine (Roberts and Janovy Jr 2000).
Infection with S. haematobium is the considered the least serious of schistosomiasis 
(Roberts and Janovy Jr 2000). Adults of this species live in the venules of the urinary bladder
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and the chief symptoms are associated with the urinary system (Roberts and Janovy Jr 2000). 
There is a gradual onset of hematuria with development of an ulcerated bladder as the disease 
progresses (Roberts and Janovy Jr 2000). These changes in the bladder wall are associated with 
a tissue-egg reaction causing the pseudotubercles, fibrous infiltration, thickening of the 
muscularis layer and ulceration (Roberts and Janovy Jr 2000). Hepatosplenic schistosomiasis is 
also common but tends to be subclinical or mild (Markell et al. 1992). Granulomas that form 
around the eggs may become lodged in the liver and become grossly enlarged (Markell et al. 
1992). Portal hypertension may result from obstructive liver disease and lead to esophageal 
varices, which may bleed, and finally to massive ascites (Markell et al. 1992).
Diagnoses
Identification of this parasite comes in the form of a positive demonstration of the eggs 
of this species in the urine (Roberts and Janovy Jr 2000). However, due to minimal numbers of 
eggs produced by the females of this genus, as compared to other helminths that infect humans 
(Roberts and Janovy Jr 2000), centrifugation or sedimentation of urine must occur for the 
recovery of the characteristics eggs (Markell et al. 1992). A more invasive approach for 
diagnostic purposes may be either a biopsy from the bladder wall or vagina of an infected 
individual (Markell et al. 1992). If conditions permit, serological tests based on the detection of 
antibodies in the patient’s blood may also be employed (Roberts and Janovy Jr 2000). 
Leishmaniasis
The species of Leishmania that infect humans are widely distributed. It is thought that 
the transport of slaves to the Western world from Africa through the Middle East and Asia 
spread Leishmania into previously uncontaminated areas, where they now apparently are 
evolving rapidly into new strains (Roberts and Janovy Jr 2000).
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Three species of Leishmania were recognized, corresponding to the clinical entities of 
cutaneous, mucocutaneous and visceral leishmaniasis (Markell et al. 1992). However, 
Leishmania donovani, the species that causes visceral leishmaniasis, locally known in India as 
Dum-Dum fever and widely known as Kala-Azar (Roberts and Janovy Jr 2000), is of interest. 
Biology
Leishmania donovani lives within the cells of the reticuloendothelial (RE) system of the 
viscera, including the spleen, liver, mesenteric lymph nodes, intestine and bone marrow (Roberts 
and Janovy Jr 2000). However, this species is not confined to the cells of the subcutaneous 
tissues and mucous membranes, but maybe found throughout the body (Markell et al. 1992).
The intermediate host and vector of L. donovani are sandflies of the genus Phlebotomus 
(Roberts and Janovy Jr 2000). When these insects ingest the blood of an infected animal, they 
also ingest amastigote forms of the parasite where they lodge in the midgut of the insect and 
begin to multiply (Roberts and Janovy Jr 2000). The parasites attach to the walls of the fly’s gut 
and replicate where they transform into promastigotes and move forward to the esophagus and 
pharynx and accumulate (Roberts and Janovy Jr 2000). The feeding sandfly pumps the 
esophageal contents in and out to clear the obstruction, thereby inoculating promastigotes into 
the skin of the victim (Roberts and Janovy Jr 2000). Once in the mammalian host, the parasite is 
immediately engulfed by a macrophage, in which it divides by binary fission, eventually killing 
the host cell, it then escapes and the process repeats severely damaging the RE system (Figure 5) 
(Roberts and Janovy Jr 2000).
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Figure 5. Life cycle of Leishmania donovani (Markell et al. 1992).
29
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Pathogenesis
Leishmania donovani does not in most areas cause skin lesions, although in some cases 
dermal lesions (presumably at the site of infecting bite) if  present may be erythematous or 
depigmented macules distributed over the entire body or in patches (Markell et al. 1992). A 
butterfly distribution over the nose is not uncommon with later lesions becoming nodular, and at 
this stage maybe mistaken for leprosy nodules (Markell et al. 1992).
It is a progressive disease, usually beginning slowly with low-grade fever and malaise, 
followed by progressive wasting and anemia, protrusion of the abdomen from enlarged liver and 
spleen, and finally death (if untreated) in two or three years (Roberts and Janovy Jr 2000). 
Accompanying this are edema, especially of the face, and bleeding of the mucous membranes 
(Roberts and Janovy Jr 2000).
However, the species that cause visceral leishmaniasis may be viewed as a disease of the 
RE system (Roberts and Janovy Jr 2000) parasitizing the cells of this system throughout the body 
(Markell et al. 1992). Proliferation of the phagocytic cells, which are so important in defending 
the host against invasion, are themselves the habitat of the parasites (Roberts and Janovy Jr 
2000). Thus, compensatory production of macrophages and other phagocytes can lead to an 
increase in parasite numbers, particularly in the spleen and liver, resulting in massive 
hypertrophy of these organs (Markell et al. 1992). Thus, splenomegaly with stasis of blood in 
the sinusoids may result in increased destruction of both red and white blood cells (Markell et al. 
1992). Also, glomerular involvement, with deposition of subendothelial and mesangial immune 
complexes resembling those found in the kidney in human cases of hepatosplenic 
schistosomiasis have been found (Markell et al. 1992).
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Diagnoses
Finding amastigotes in tissues or secretions, such as a spleen or liver puncture, blood or 
nasal smears, bone marrow, should be examined and cultures from these should be attempted 
(Roberts and Janovy Jr 2000). However, such procedures may be risky, such as a spleen 
puncture, or not as productive as one would like, such as a liver puncture (Markell et al. 1992). 
Culturing of the parasite is an alternative method. It was found that Schneider’s Drosophila 
medium, microscopy using Giemsa-stained smears, RPMI medium 1640, andNNN medium 
were found to range from most to least sensitive, respectively, for detection (Markell et al. 1992). 
Also, fluorescent antibody tests, enzyme-linked immunosorbent assay (ELISA) (Harith et al. 
1987), and direct agglutination test (DAT) have been developed (Pappas et al. 1984). However, 
one of the most simplistic means of identification could be the elimination of the diseases that 
have symptoms similar to Kala-Azar (Roberts and Janovy Jr 2000).
Trypanosomiasis
Trypanosomiasis is the recognized term for a disease caused by species within the genus 
Trypanosoma generally referred to as trypanosomes. Trypanosomes are agents of numerous 
diseases of humans in subtropical and tropical regions of the world (Ruppert and Barnes 1994). 
They are divided into two broad groups, or “sections”, based on characteristics of their 
development in the insect hosts (Roberts and Janovy Jr 2000). If a species develops in the 
anterior portions of the digestive tract, it is said to undergo anterior station development and is 
relegated to the section Salivaria, such as in the case of Trypanosoma brucei, but if  a species 
develops in the hindgut of its invertebrate host, it is said to undergo posterior station 
development and is placed in the section Stercoraria, such as in the case of Trypanosoma cruzi 
(Roberts and Janovy Jr 2000). In general, part of the life cycle of these parasites is passed within
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or attached to gut cells of blood-sucking insects, and another part of the cycle is spent in the 
blood or in white blood cells and lymphoid cells of the vertebrate host, although other tissues 
may be invaded (Ruppert and Bames 1994). Intracellular stages are aflagellate, but during the 
life cycle there are motile, extracellular flagellate stages in the bloodstream or in the invertebrate 
host (Ruppert and Bames 1994).
Trypanosoma brucei
African sleeping sickness is the name given to the disease caused by two subspecies of 
Trypanosoma brucei: T. b. gambiense, which is the cause of Gambian or the West African form 
of the disease, and T. b. rhodensiense, which causes Rhodesian or East African sleeping sickness 
(Markell et al. 1992). However, due to the similarity between the life cycles of each subspecies, 
their biology will be described in terms of the T. brucei complex. This parasite occurs as 
trypomastigotes in the bloodstream, lymphatics, and cerebrospinal fluid, although, it has been 
reported to occur as nonflagellate cryptic forms in the choroids plexus, and possibly other organs 
(Markell et al. 1992).
Biology
The insect vectors, tsetse fly, that participate in the life cycle of T. brucei fall within the 
genus Glossina (Roberts and Janovy Jr 2000). When the parasite is ingested by the fly, along 
with a blood meal, T. brucei locates in the posterior section of the midgut of the insect where it 
multiplies in the trypomastigote form for about 10 days (Roberts and Janovy Jr 2000). Migration
til fhof the parasite into the foregut occurs between the 12 and 20 day of development, followed by 
further migration into the esophagus, pharynx, and hypopharynx where they enter the salivary 
glands and transform into epimastigotes (Roberts and Janovy Jr 2000). Several asexual 
generations produces metacyclic trypomastigotes, the only stage in the vector that is infective to
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the vertebrate host, and when feeding, the tsetse fly may inoculate the host with several thousand 
flagellates (Figure 6) (Roberts and Janovy Jr 2000).
Once in the vertebrate host, the trypanosomes multiply as trypomastigotes in the blood and 
lymph (Roberts and Janovy Jr 2000). In chronic situations, many invade the central nervous 
system, multiply, and enter intercellular spaces within the brain (Roberts and Janovy Jr 2000). 
Pathogenesis
Initially in human infections, a small sore (chancre) often develops at the site of 
metacyclic trypanosome inoculation but soon may disappear after one or two weeks (Roberts and 
Janovy Jr 2000). These protozoa then gain entrance to the blood and lymph channels, where 
they reproduce rapidly, producing a parasitemia and invading nearly all organs of the body 
(Roberts and Janovy Jr 2000). It is at this stage that the similarities between the two subspecies 
begin to lessen.
Trypanosoma brucei rhodensiense rarely invades the nervous system, but usually causes 
a more rapid course toward death when compared to T. b. gambiense (Roberts and Janovy Jr 
2000). Once this parasite reaches the lymph channels, the lymph nodes in the neck, groin and 
legs become swollen and congested, with a characteristic swelling of the nodes at the base o f the 
skull referred to as Winterbottom’s sign (Roberts and Janovy Jr 2000). Weight loss is common 
with involvement of the heart, resulting in death within a few months (Roberts and Janovy Jr 
2000). However, there is no sign of somnambulism or other protracted nervous disorders as with 
T. b. gambiense due to rapid death of the host (Roberts and Janovy Jr 2000).
Early in infection, T. b. gambiense is found in the choroids plexus where a blockage of 
capillaries may occur causing localized edema and obstruction of the cerebral spinal fluid 
(Markell et al. 1992). In the acute stage of infection, evidence suggests that it may be due to
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Figure 6. Life cycle of Trypanosoma brucei complex (Markell et al. 1992),
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antigenic “performance” of trypanosomes and the host’s immune reaction (Roberts and Janovy Jr 
2000). At this stage, trypanosome antigens adsorb to the surface of some host cells, such as red 
blood cells, causing lysis and accounting for the resultant anemia (Roberts and Janovy Jr 2000). 
In the chronic stage of infection, trypanosomes invade the central nervous system (Roberts and 
Janovy Jr 2000). Mental and physical instabilities follow, which may lead to coma and death 
resulting from malnutrition, pneumonia, heart failure, or other parasitic infection (Roberts and 
Janovy Jr 2000).
Diagnoses
Demonstration of parasites in the blood, bone marrow or cerebrospinal fluid established 
diagnosis (Roberts and Janovy Jr 2000). Centrifugation of the spinal fluid increases the 
possibility of trypanosome detection, however, it was found that double centrifugation was at 
least twice as sensitive as single centrifugation and increased the early detection of late-stage 
cases (Markell et al. 1992). Serological tests for T. brucei identification include 
immunofluorescence (IIF), indirect hemagglutination (IHA), ELISA and complement fixation 
techniques: serum and spinal fluid immunoglobulin M (IgM) measurements (Markell et al.
1992). Differential diagnosis between the subspecies may be made on geographical grounds, but 
there are some areas, such as Uganda, where the two infections coexist, therefore much reliance 
in placed on the patient’s clinical history and physical findings (Markell et al. 1992). 
Trypanosoma cruzi
The etiological agent of Chagas’ disease or American trypanosomiasis is Trypanosoma 
cruzi. This protozoan parasite is distributed throughout some southern parts of the United States 
through Mexico and Central America, and in South America as far south as Argentina (Markell 
et al. 1992). This organism differs from other trypanosomes infecting humans in that it has an
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intracellular amastigote stage in cardiac muscle and other tissues, as well as trypanosome forms 
in the circulating blood (Markell et al. 1992).
Biology
Trypanosoma cruzi develops successfully in a large number of insects, but it is 
considered that reduviid bugs are the only vectors of importance and only those species that 
invade houses and habitually defecate during the process of feeding or immediately thereafter are 
major vectors of the human disease (Markell et al. 1992). Their feces may contain metacyclic 
trypanosomes, which gain entry into the body of the vertebrate host through the bite, scratched 
skin, or mucous membranes that are rubbed with fingers contaminated with the insect’s feces 
(Roberts and Janovy Jr 2000). Trypomastigotes do not reproduce until they have entered a cell, 
such as reticuloendothelial cells of the spleen, liver, and lymphatics and cells in cardiac, smooth, 
and skeletal muscles, and have transformed, by binary fission, into amastigotes killing and lysing 
the cell (Roberts and Janovy Jr 2000). Some intermediate forms (promastigotes and 
epimastigotes) complete the metamorphosis into trypomastigotes and find their way into the 
blood (Roberts and Janovy Jr 2000).
Trypomastigotes ingested by triatomine bugs pass through to the posterior portion o f the 
insect’s midgut, where they become short epimastigotes, multiply by longitudinal fission, and 
eight to 10 days later, metacyclic trpomastigotes appear in the insect’s rectum(Roberts and 
Janovy Jr 2000). These pass with the feces, and once inoculated into a mucous membrane or 
wound in the skin, the cycle begins again (Figure 7) (Roberts and Janovy Jr 2000).
Pathogenesis
Upon its entry into the vertebrate host, T. cruzi produces an acute local inflammatory 
reaction (Markell et al. 1992). Within one to two weeks of infection, the metacyclic
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Figure 7. Life cycle of Trypanosoma cruzi (Markell et al. 1992).
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trypanosomes spread to the regional lymph nodes and begin to multiply in the cells that 
phagocytose them, generating an accumulation intracellular amastigotes, which produces a so- 
called pseudocyst (Roberts and Janovy Jr 2000). Trypomastigotes that burst out of the 
pseudocyst cause an acute, local inflammatory response, with degeneration and necrosis (cell or 
tissue death) of nerve cells in the vicinity (Roberts and Janovy Jr 2000).
An acute phase of the disease is initiated by inoculation into the wound of the 
trypanosomes from the bug’s feces resulting in a local inflammatory response and producing a 
small red nodule known as a chagoma (Roberts and Janovy Jr 2000). Lipogranulomas form after 
the lymphatic spread of the parasites to the regional nodes (Markell et al. 1992). Pseudocysts 
may be found throughout the body, as the disease progresses, invading the heart muscle and 
resulting in an 80% loss of the cardiac ganglion cells (Roberts and Janovy Jr 2000).
The chronic phase of the disease revolves mostly around the heart and surrounding 
tissues. Massive cardiomegaly may develop, with diffuse inflammation of the myocardium as 
well as fibrosis and infiltration of lymphocycts, macrophages, and plasma cells, and the heart 
weight increases (Markell et al. 1992). Damage to the autonomic nervous system of the heart 
parallels that to Auerbach’s plexus in the walls o f the digestive tract (Markell et al. 1992). 
Hypertrophy of the muscle layers and diminution in number of the ganglion cells are seen in 
affected portions of the digestive tract, most frequently in the esophagus and colon (Markell et 
al. 1992).
Diagnoses
Positive identification of this parasite may rely on the demonstration of trypanosomes in 
blood, cerebrospinal fluid, fixed tissues or lymph, with trypomastigotes most abundant in 
peripheral blood during periods of fever via smear of biopsy (Roberts and Janovy Jr 2000). In
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young children, this technique is easily accomplished, however, in older children and adults, it is 
more difficult thus requiring concentration techniques or culture (Markell et al. 1992). Blood 
can be inoculated into a suitable host animal (guinea pig, mouse) where heart smears from these 
animals can be examined for the presence and identification of the parasite (Roberts and Janovy 
Jr 2000). Xenodiagnosis may also be employed. This technique involves the use of laboratory- 
reared triatomines, which are allowed to feed on a patient and after a suitable period of time (10 
to 30 days) they are examined for intestinal flagellates (Roberts and Janovy Jr 2000). A more 
specific test, a complement fixation test referred to as the Machado-Guerreiro test, relies on 
antigen specificity or radioimmunoassay (RIA) developed for immunodiagnosis (Markell et al. 
1992).
Ascariasis
Ascariasis is a disease caused by two species of Ascaris: A. lumbricoides and A. suum, 
however, it is the species that causes the human form of the disease that is of interest. Ascaris 
lumbricoides, and the species in general, are characterized by their great size; females ranging 
from 20cm to 49cm long and 3mm to 6mm wide, and males 15cm to 31cm long and 2mm to 
4mm wide; having three prominent lips, each with a dentigerous ridge, and no interlabia or alae 
(Roberts and Janovy Jr 2000). Both sexes are creamy white, sometimes with a pinkish cast, and 
the cuticle has fine circular striations (Markell et al. 1992).
Mature female worms can produce up to 200 000 eggs daily, each recognizable once 
fertilized (Markell et al. 1992). These fertilized eggs are oval to round, 45pm to 75pm long by 
35pm to50pm wide, with thick, lumpy outer shell (mammallated, uterine or proteinaceous layer) 
(Roberts and Janovy Jr 2000).
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The possibility of infection with A. lumbricoides is common. This nematode is quite 
abundant and has a cosmopolitan distribution (Roberts and Janovy Jr 2000). Infection persists 
throughout the temperate and tropical areas of the globe, and under conditions of poor sanitation 
virtually 100% of the population harbour the parasite (Markell et al. 1992).
Biology
Infection with Ascariasis begins when unsegmented eggs are passed; under favourable 
conditions they require a period of about two or three weeks outside the host to develop to the 
infective stage (Markell et al. 1992). When the fully embryonated eggs are swallowed with 
either contaminated food or water, they hatch in the duodenum, penetrate the mucosa and 
submucosa and enter the lymphatics or venules (Roberts and Janovy Jr 2000). After passing 
through the right heart, they enter the pulmonary circulation and break out of capillaries into air 
spaces (Roberts and Janovy Jr 2000). There they grow and molt, and after about 20 days migrate 
through the respiratory passages to reach the esophagus and eventually once again the small 
intestine (Markell et al. 1992). Two or three months after ingestion of the eggs, the mature 
worms commence egg laying in the intestine (Figure 8) (Markell et al. 1992).
Pathogenesis
Damage caused by ascarids is initiated when juveniles break out of lung capillaries into 
the respiratory system, where they cause a small hemorrhage at each site (Roberts and Janovy Jr 
2000). However, with heavy infections, small pools of blood may accumulate, which may 
initiate edema with resultant clogging of air spaces by white blood cells and dead epithelium 
known as Ascaris pneumonitis (Roberts and Janovy Jr 2000).
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Figure 8. Life cycle of Ascaris lumbricoides (Roberts and Janovy Jr 2000).
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It is not uncommon for female worms to leave the intestine. This occurs from a lack of 
male presence and/or overcrowding, commonly known as “wandering worms” (Roberts and 
Janovy Jr 2000). If worms wander downstream, they make their way to the appendix, which can 
be clogged or penetrated, or to the anus (Roberts and Janovy Jr 2000). Upstream wandering 
leads to the pancreatic and bile ducts, possibly occluding them with grave results (Roberts and 
Janovy Jr 2000). Worms reaching the stomach are aggravated by the acidity and writhe about, 
causing nausea (Roberts and Janovy Jr 2000). Suffocation or lung damage is possible if  the 
worms reach the esophagus and crawl into the trachea; may crawl into the eustachean tubes and 
middle ears causing damage; or may simple exit through the nose or mouth, causing predictable 
consternation (Roberts and Janovy Jr 2000).
Diagnoses
A highly used method to diagnose this parasite involves identifying the characteristic, 
mammillated eggs in stool, or by the worm itself (Roberts and Janovy Jr 2000). There are 
usually an abundance of eggs, therefore, one or two direct fecal smears are usually sufficient to 
demonstrate infection (Roberts and Janovy Jr 2000). Providing there is an experienced 
technician with an abundance of experience identifying juveniles of this species, demonstration 
of the juveniles in the sputum via a smear is a definite diagnostic tool (Roberts and Janovy Jr
2000). Other methods, slightly more tiresome on the patient, involves the diagnosis of the 
parasite on radiography, either as worm-shaped radiolucent areas in a barium-filled intestine, 
sometimes with their own intestinal tracts outlined as well by the barium they have ingested, or 
in cholangiograms (Markell et al. 1992).
Although the methods used in these simplistic, conventional diagnostic procedures seem 
to allow for an accurate identification of the parasite, there are a few disadvantages with the
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methods. Firstly, the more invasive the test, the less likely patients would be willing to go 
through such a procedure. For all of the parasites outlined, microscopic identification of the 
parasite was the most efficient method and the most commonly used. However, only a minimal 
number of slides may be read by one microscopist per day, which makes this method rather 
unsuitable for application in large epidemiological field situations (Jelinek et al. 1996), and an 
expert is usually required for each species identification. Finally, with the more advance 
serological tests, several problems do still exist. Many times, these tests only become positive 
some time after infection, they only become negative some time after cure, many tests cannot 
differentiate between closely related species or between current and cured cases of the disease, 
and many cross react with other species of the same genera, such as in helmintic infections 
(Roberts and Janovy Jr 2000). That is why new techniques are required, which allow for 
specific, efficient, and immediate diagnosis of disease. One such technique that falls within all 
these parameters is the polymerase chain reaction.
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CHAPTER 3: PARASITE DIAGNOSTICS VIA PCR
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Parasites and PCR
The PCR technique has been an innovative tool in molecular analyses of DNA. This 
technique has been able to revolutionalize molecular research through its ability to progress 
alongside all other techniques, although decades old. It has stood firm on its own and in 
combination with other techniques to still be considered a “new” molecular technique. Thus, 
through innovative research methodology and expanding knowledge of biological properties, 
PCR has opened up new horizons to how research employs critical analyses of nucleic acids. 
With this and alongside other ground-breaking techniques, it has given rise and provided us with 
substantial research inquiries into the realm of parasite analyses via nucleic acid research.
An abundance of research involving PCR has been performed on DNA analyses of 
various parasites. Kinetoplast DNA (kDNA) has been used extensively in research and 
identification of L. donovani, such as the identification of species from mixed infections 
(Ibrahim et al. 1994) or testing for the presence of the parasite in unknown or suspected samples 
showing signs of disease (Smyth et al. 1992; Bhattacharyya et al. 1996; Salotra et al. 2001) and 
finding a correlation between seroreactivity of the multicopy mini-exon derived RNA (med 
RNA).
Other parasites have also been examined. DNA studies suggested that S. haematobium or 
a hybrid of S. haematobium and Schistosoma mattheei parasite infected dog in Zambia (Chiti et 
al. 1999), and Dral repeat could be used for monitoring free-living cercariae and infected snails 
only in bodies free from cross-hybidizing species of Schistosoma (Hamburger et al. 2001). 
Trypanosome PCR analyses have also provided a means to identify species, whether it be a 
determination of optimal oligonucleotides for T. cruzi (Virreira et al. 2003) through the 
determination of allelic frequencies in geographical areas and nature of multilocus genotypes in
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two geographically separate T. brucei stocks (Mbati et al. 1999), or to determine how effective 
drug treatment against T. brucei is (MacLeod et al. 2001). However, PCR analyses involving a 
combination of methods have expanded the utility of PCR.
A combination of two PCR techniques has been termed nested PCR. It involves a PCR 
followed by a subsequent PCR with primers of the second flanking a region inside or outside the 
first PCR primers, and the initial PCR product used as the template. Many investigators have 
used nested PCR in parasite analyses. With Plasmodium species geographical distributions 
overlapping, nested PCR has been used to identify the distribution of mixed species (Mehlotra et 
al. 2000) or to establish the genetic structure of P. falciparum in areas with a different degree of 
endemicity (Montoya et al. 2003). Also, linkage disequillibrium was analyzed to determine the 
frequency of recombination events in merozoite surface protein-1 (MSP-1) (Sakihama et al. 
2001). In addition to this, a technique referred to as heminested PCR was used to genetically type 
T. cruzi lineages I and II (Freitas et al. 2005).
Combining immunological methods and PCR has proven effective in research. PCR- 
ELISA has demonstrated its reliability for diagnosing visceral leishmaniasis when compared to 
direct examination and culture (Costa et al. 1996). However, when investigating T. brucei 
parasitemia, PCR-ELIS A, although increasingly more effective than microscopy, only produced 
an efficiency of 85% (Masake et al. 2002). The addition of microplate hybridization (MPH) to 
PCR based ELISA (PCR-MPH) was used to target the DNA sequence of the 8S small subunit 
ribosomal RNA (rRNA) gene and hybridize with species-specific probes for P. falciparum 
(Laoboonchai et al. 2001). Thus, combining PCR with techniques that are solely efficient has 
proven a reliable means of parasite analysis.
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Genetic characterization of parasites has revolved around randomly amplified 
polymorphic DNA (RAPD). RAPD was used to describe the phylogenetic groups of T. cruzi (I 
and II) (Zalloum et al. 2005). It was used to examine the relationship between genetic diversity 
of S. haematobium and the clinical outcome of samples (Brouwer et al. 2003), to examine the 
genetic diversity occurring in a population of schistosomes (Shiff et al. 2000), and to cross- 
sectionally study the genetic population structure of the Bulinus globosus-Schistosoma 
haematobium system (Davies et al. 1999). Also, relatedness was analyzed between T. brucei, 
Trypanosoma evansi and Trypanosoma equiperdum (Lun et al. 2004).
Fragment length polymorphisms in combination with PCR have provided many 
techniques for DNA analyses. Differentiation between species, subspecies, groups or hosts are a 
few applications of this technique. Restriction fragment length polymorphism (RFLP) combined 
with PCR has been used to differentiate between P. vivax and P. falciparum (Patsoula et al.
2003), between S. haematobium and Schistosoma bovis (Barber et al. 2000) and to show A. 
lumbricoides infections in dogs (Traub et al. 2002) and pigs (Zhu et al. 1999). Combined with 
amplified fragment length polymorphism (AFLP) analysis, a technique for whole genome 
fingerprinting, it was able to provide information that humans had acquired Ascaris from pigs 
and may therefore be considered a zoonotic disease (Nejsum et al. 2005).
A PCR based method for the quantitation of parasite infections involves the use of real­
time PCR. This method has proven its accuracy and sensitivity on many occasions. This 
methodology was used to amplify a 195-bp repeat in T. cruzi DNA with accurate identification 
and quantitation of tissue parasite burden in animals (Cummings and Tarleton 2003). Primers 
designed for targeting a 177-bp repeat satellite DNA of T. brucei were designed and applied
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using real-time PCR to human blood and found to be efficient, rapid and sensitive (Becker et al.
2004).
A more innovative approach in parasite identification involves the amplification process 
of converting RNA to DNA. This method, known as reverse transcriptase PCR (RT-PCR), has 
been used in numerous studies. It has proven to be a sensitive and specific method for P. 
falciparum detection (Abdullah et al. 1996). RT-PCR analyzed the migratory pattern of three 
schistosomes through human skin via cytokine pattern analysis (Poinar 2003). Following 
suppression subtractive hybridization analysis, RT-PCR further validated the identification of 
differentially expressed genes in different T. cruzi strains, but no specific correlation between 
gene expression and the classification of groups could be found (Dost et al. 2004).
As seen, there are many PCR-based techniques for parasite identification. The parasites 
investigated and presented are of great interest and importance to parasitological studies. They 
offer insights into genus and species biology, ecology distribution, which coincides with 
society’s life and well being. Therefore, further molecular analyses involving each species will 
be investigated and discussed.
Parasites and Multiplex PCR
Multiplex PCR has been used in a variety of applications involving parasites. Many 
investigations focus on the differentiation of species when working with multiplex PCR because 
many species have morphologic and symptomatic similarities that classic diagnostic procedures 
would not be feasible, or singleplex PCRs too time consuming. The use of multiplex PCR has 
greatly enhanced the specificity of molecular analyses as well as providing a more sensitive and 
less time consuming technique.
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This analysis has been able to enhance the identification of species by increasing the 
number of targets analyzed in a single reaction. By applying this methodology and using 
minisatellite repeats from Schistosoma mansoni mitochondria DNA (mtDNA) for multiple 
targets, this parasite was found to be the cause of infection in one intermediate host, 
Biomphalaria glabrata (Jannotti-Passos et al. 1997). Multiplex PCR for the identification of 
various strains of a single species has been used to identify P. falciparum (Sidhu and Madhubala
2000) or to confirm that dual drug-resistant clones carried both episomal drug-resistant marker 
plasmids from T. cruzi lineages I and II, revealing a genetic exchange (Stothard et al. 1999). 
Other researchers have taken this approach further and used multiple species targets.
Differentiation between genus and species has increased the specificity of detection. 
Using targets designed specifically for the genus, and others designed to be species-specific 
would allow for production of an amplification product of at least one target if the genus is 
present. This technique has been applied to a variety of clinical samples in order to detect 
Leishmania braziliensis complex (Belli et al. 1998). The use of a multiple competitive real time 
PCR was used to detect either Plasmodium or P. falciparum with a diagnosis in two hours (Fabre 
et al. 2004). However, more common is the differentiation and identification between species of 
the same genus.
The spliced leader (mini-exon) gene repeats was targeted in a multiplex PCR for 
differentiation of the three New World Leishmania complexes (L. braziliensis, L. mexicana, L. 
donovani) (Harris et al. 1998). Due to the morphological similarities and overlapping 
geographical and host distributions T. rangeli and T. cruzi I and II, differentiation via multiplex 
PCR is common (Souto et al. 1999; Fernandes et al. 2001). Utilizing a multiplex real time PCR, 
species-specific probes were created for the causative agents of human malaria: P. falciparum, P.
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vivax, P. malariae and P. ovale (Rougemont et al. 2004). Differential diagnosis between P. 
falciparum and P. vivax from blood has been studied on many occasions (Zaman et al. 2001;
Kho et al. 2003; Patsoula et al. 2003), as well as between all four human malaria species (Rubio 
et al. 1999; Patsoula et al. 2003), whether in single or mixed infections. Even the differentiation 
between intermediate hosts has begun, such as in the creation of distinct profile for B. glabrata, 
B. tenagophila and B. straminea, intermediate hosts of S. mansoni (Jannotti-Passos et al. 1997). 
Therefore, due to the rapid nature of this detection system, able to increase the sensitivity and 
specificity as well as the use of multiple target analysis in one reaction, multiplex PCR has begun 
to modernize the world of molecular analyses.
Parasites and aDNA Analyses
The absence of evidence of a pathogen in any given human remains is not evidence of its 
absence (Herrmann and Hummel 1998). The vast majority of infectious diseases in ancient 
populations cannot be diagnosed directly because they are undetectable: most of them are not 
bone-seeking disease, and even bone-seeking infectious disease cause characteristic tissue 
alterations only after a more or less long-term chronic infection (Herrmann and Hummel 1998). 
Due to the nature of parasitic diseases, we usually look for evidence of the disease in the past 
which almost exclusively comes from two kinds of source material: (i) historical material: 
written sources, tools for medical treatment, pharmacological materials indicating the presence 
of diseases (sometimes even specific diseases); and (ii) biological materials that are the 
substrates for diseases: remains of humans or other organisms bearing signs of diseases, 
sometimes enabling specific diagnosis (Herrmann and Hummel 1998). Once all preliminary 
factors have been investigated, following through with aDNA analysis is the next step.
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PCR-based amplification of specific DNA fragments are used to amplify ancient DNA 
(aDNA) residues in human remains to provide evidence for a presumed infectious disease (Zink 
et al. 2002). Success with this technique came in the 1990s on a 1000-year-old South American 
mummy (Salo et al. 1994), and an Egyptian mummy from the New Kingdom (1550-1080 BC) 
(Nerlich et al. 1997), in which Mycobacterium tuberculosis DNA was detected. Several other 
microbes have been detected in the following years widening the diagnostic ability, such as 
Mycobacterium leprae (Rafi et al. 1994), Yersinia pestis (Drancourt et al. 1998), Plasmodium 
falciparum (Taylor et al. 1997), Trypanosoma cruzi (Guhl et al. 1999), Treponema pallidum 
(Kolman et al. 1999), Escherichia coli (Fricker et al. 1997), Ascaris spp. (Loreille et al. 2001) 
and Corynebacterium spp (Zink et al. 2001), which were mostly based on single findings or on 
small series of selected samples (Zink et al. 2002).
Plasmodium falciparum was identified as the causative agent of disease when a semi­
nested PCR developed for identifying Plasmodium species nucleic acid was applied to two 
human rib bones from separate individuals who had died almost 60 years previously with anemia 
thought to be due to malaria (Taylor et al. 1997). A hemi-nested PCR, employing primers 
designed to anneal to part of the 18S ribosomal RNA (rRNA) genes of the four Plasmodium 
species, which infect humans, was used to amplify successfully malarial DN A from a rib bone 
from one individual who had died in 1937 with anemia believed to be caused by malaria, and P. 
falciparum was confirmed as the pathogen by sequencing the PCR product and obtaining a 98% 
sequence identity (Sallares and Gomzi 2001).
A PCR-based identification system amplifying a fragment of kinetoplast DNA from T. 
cruzi was used to identify the species from spontaneously desiccated mummified tissue from the 
coastal areas of the Atacama desert of northern Chile (Guhl et al. 1999) and from coastal and low
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valley sites in northern Chile and southern Peru (Aufderheide et al. 2004). Aufderheide and 
colleagues (2004) further analyzed the amplified PCR products by reacting (hybridizing) them 
with a species-specific probe to discover a 41% positive identification. PCR amplification of the 
conserved region of the minicircle molecule found four of six mummified abdominal/chest 
cavity tissue samples positive for T. cruzi (Ferreira et al. 2000). The amplified products 
corresponding to genetic fragments of the parasite were then tested by hybridization 
experiments, with positive results for T. cruzi specific molecular probe (Ferreira et al. 2000).
To date, only one study has been published regarding the identification of Ascaris from 
archaeological remains. Coprolites mixed with soil organic matter were recovered from a 15th 
century latrine from the Middle-Age site of ‘Place d’Armes’ in Namur (Belgium) (Loreille et al. 
2001). The parasitic eggs discovered in the remains were morphologically identified as Ascaris 
sp. (Loreille et al. 2001), however, PCR amplification would further confirm this identification. 
Thus, PCR was used to amplify and sequence fragments of the cytochrome b and 18S rRNA 
genes in the 600-year-old Ascaris eggs (Loreille et al. 2001). It was found that the 18S rRNA 
sequence was identical to that of A. suum, but the cytochrome b sequence exhibited two and 
three substitutions when compared to A. lumbricoides and A. suum respectively (Loreille et al.
2001). Therefore, it was difficult to identify the species present because there was no 
archaeological evidence to favour one of these identifications (Loreille et al. 2001).
When working with parasites and disease, it must be remembered that it is known that 
many infections are asymptomatic, and even when death does occur, it is frequently caused not 
by the agent alone, but by the synergistic interactions with other diseases (Sallares and Gomzi
2001). Thus, it would not be surprising if  it turned out to be impossible in practice to detect 
many cases of disease in the past using even the most sophisticated biomolecular techniques
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which could be devised (Sallares and Gomzi 2001). Thus the preservation of the specimen and 
the parasites must be taken into consideration when working with PCR and ancient material. 
Parasites utilize their human host for growth and sometimes reproduction, but if that host dies, 
the parasite dies along with it. There have been few evolutionary defence mechanisms evolved 
by the parasite to avoid death once host death has occurred, such as in bacteria that initiate the 
formation of a cyst when the environment is not suitable for survival. Therefore, the majority of 
parasites will succumb to DNA degradation similar to that of its human host. Thus PCR 
methods must take into consideration the degradation of the parasitic DNA, therefore a minimum 
of three criteria for malaria detection methods have been imposed: high sensitivity, rapidity, and 
simplicity (Tirasophon et al. 1994).
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CHAPTER 4: MOLECULAR DETECTION AND IDENTIFICATION OF PARASITES 
INVOLVED IN HUMAN DISEASE: METHODOLOGICAL OPTIMIZATION
54
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The field of molecular research involving the use of nucleic acids and the PCR technique 
has expanded throughout the decades. An increase of information available to researchers has 
provided a basis of study involving many aspects of parasitic disease diagnoses, parasite 
identification and an understanding of the factors involved when these parasites interact with 
humans today. Therefore, the following study explores the basis of molecular analyses of the six 
parasites: (1) Plasmodium falciparum, (2) Schistosoma haematobium, (3) Leishmania donovani, 
(4) Trypanosoma brucei, (5) Trypanosoma cruzi and (6) Ascaris lumbricoides, via PCR and 
nucleic acid research.
Objectives
1. To design and develop methods of detection and identification that are highly specific 
and highly sensitive for each parasite involved in disease by utilizing the PCR technique 
and nucleic acid based technology in three steps:
STEP I: parasite identification via PCR
STEP II: parasite identification via multiplex PCR
STEP III: multiple parasite identification via multiplex PCR.
2. Application of the technique to degraded DNA samples to study the presence of disease 
and the causative species:
Degraded DNA Analysis I: parasite identification in medical archived samples 
Degraded DNA Analysis II: parasite identification in archaeological samples. 
Institute of Study
This study was conducted at the Paleo-DNA Laboratory on campus at Lakehead 
University in Thunder Bay, Ontario, Canada.
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Materials and Methods 
Primer Design
Genes within the genome of each species were chosen as targets to design sets of species- 
specific oligonucleotide primers on the basis of literature research and stability and function 
within the genome using the sequence of each species as templates (Table 1). Initial design 
began with locating a suitable sequence of bases within an 18 to 30 base-length and coupling 
with a second sequence to produce an amplicon size of no greater than 300 bp. A standard 
nucleotide-nucleotide BLAST (blastn) (Altschul et al. 1997) search was performed on each 
individual primer to verify the species-specific origin of the sequence of the sequence in 
question, followed by the determination of disassociation temperature using QIAGEN’s Oligos 
Toolkit (http://oligos.quiaaen.com/oligos/toolkit.php). Amplicon analysis continued with a 
computer simulated PCR program (Amplify version 1.2 for Mac software) to determine the 
primability and stability of match, and to visualize the sensitivity and specificity of match of 
each amplicon.
General Laboratory Procedures
Certain precautions were taken to guard against contamination of the sample with 
extraneous DNA: (i) double gloves were worn (frequently changed when moving stations); (ii) 
PCR preparation and analysis was performed in three separate areas: one area for PCR reagent 
set-up (hood), one area for PCR itself, and one area for PCR analysis; (iii) sterile disposable 
laboratory instruments were utilized whenever possible, as well as positive displacement pipettes 
and barrier-tipped pipette tips, with each area containing its own set of equipment that were not 
interchanged; (iv) all areas prior to and following use were thoroughly cleaned using 10% 
sodium hypochlorite, ddH20, 70% ethanol, and hoods were UV irradiated for at least 30
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Table 1. Sequences of primers used for each species.
Parasite: Plasmodium falciparum
Primer Sequence 5' to 3 ' Genom e Position bp T,n Source NCBI Nucleotide
(°C) Accession Position
DHFR AAT GAT GAC AAA GAT ACA TG DHFR-TS 280 52.2 (Arai et al. J04643 757-776
-TS3 1994)
DHFR TTC GAT CAC TTT GTT TAT TTC CAT T DHFR-TS 56.4 (Arai et al. 1036-1012
-TS2 1994)
KI-14- CGT GTA CCA TAC ATC CTA CCA AC pB R K l-14  clone 206 63.5 (Jelinek et al. AF003109 538-560
P2 1996)
KI-14- GCT ACA TAT GCT AGT TGC CAG AC pB R K l-14  clone 63.5 (Jelinek et al. 742-720
P1 1996)
M SA- GAG TTC TTT AAT AGT GAA CAA G MSA-1 100 55.9 (Laserson et M55001 301-282
1B al. 1994)
M  SA­ GGT GCT GCA AAT CCT TCA GAT GAT T MSA-1 62.9 THIS 202-226
ID STUDY
MSA- GTT CCA CCC ACT CAA GAT GC MSA-2 131 62.4 THIS L I9052 472-491
2 0 STUDY
MSA- CCT GTA CCT TTA TTC TCT GG M SA-2 58.3 (Laserson et 602-583
2 8 al. 1994)
Parasite: Schistosoma haematobium
Primer Sequence 5 ' to 3' Genome Position Bp Tm Source NCBI Nucleotide
(°C) Accession Position
SH2F ACG GAA AAC AAA GCG CAC CAC Ribosomal 1GS 85 63.3 THIS AJ223838 1083-1103
STUDY
SH2R CTT TAC ACA TGG TCT TAC TCG CC Ribosomal IGS 63.5 THIS 1167-1145
STUDY
SH3F TAG TTT CTA ACC GAG ATG TCA AG nad6 (modified) 121 59.9 (Kane et al. AJ271051 2191-2213
2003)
SH3R CC T AAA CCT GAC CCA TAC TTA TC Partial mito. 61.7 THIS 2311-2289
genome STUDY
SH5F GAT TTT TTG GTC ATC CAG AGG TG Cytochrome C 161 61.7 THIS AY157209 608-630
oxidase STUDY
SH5R GGC TCA AAC TAC ACT TCC TAA G Cytochrome C 61.5 THIS 768-747
oxidase STUDY
SH6F GCA CTT AGA GAG GCA CAA CTC Egg shell protein 128 63.3 THIS M27659 150-170
STUDY
SH6R GAG CGA CGA TCT CAT TTT TCC Egg shell protein 61.4 THIS 278-258
STUDY
Parasite: Leishmania donovani
Primer Sequence 5' to 3' Genome Position Bp Tm .  Source NCBI Nucleotide
(°C) Accession Position
LD1F TGC GTG CGT GTG TGT GAC ATC IMP-D 116 65.3 THIS M55667 382-402
STUDY
LD1R TAC GTC AGT CCA TCG CCC CG IMP-D 66.5 THIS 497-478
STUDY
LD2F AGA CAA GCT GGG TCG TAA CTC AAP13LD 129 63.3 THIS AY453650 201-221
STUDY
LD2R AAG ACG ACG AGG TAG CCA ATA G AAP13LD 63.4 THIS 329-308
STUDY
LD3F GGA GTA GCC TCA GGA CTT TAG Kinetoplast 182 63.7 (Salotra et al. Y11401 541-561
minicircle 2001)
LD3R TAG GTA CAC TCT ATC AGT AGC AC Kinetoplast 61.7 THIS 722-700
minicircle STUDY
LD4F GCT GGA AGT GAA GGT TGT CTG C Adenylate kinase 218 65.2 THIS AF156853 189-210
STUDY
LD4R GAT AGA TGC GTC CCG ACT TGG Adenylate kinase 65.3 THIS 406-386
STUDY
Parasite: Trypanosoma brucei
Primer Sequence 5 ' to 3 ' Genom e Position Bp Tm Source NCBI Nucleotide
CO Accession Position
TB3F TCG GGC AGG ATT TTC GTA TGG Aspartate 157 62.5 THIS AF326990 29-49
aminotransferase STUDY
TB3R CTT GCA ATT CCT GTG ACT GGG Aspartate 62.5 THIS 185-165
aminotransferase STUDY
TB7F TCA  GGT TGA GAA GAT TGG CGA AG P-type ATPase 124 62.7 THIS M73769 1698-1720
gene STUDY M37894
TB7R TTT CCA TTT CCC CTC GCA AAG TG P-type ATPase 62.7 THIS 1821-1799
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gene STUDY
21F TTT AGO GGC GGT CAC TTT TCA  C HSP70 gene 108 63.4 THIS
STUDY
M32140 1991-2012
21R CCT CGT CAT GTC TAT TAT CCT CTT G FISP70 gene 62.9 THIS
STUDY
2098-2074
22F CTA AAC GTC TCG GCG ACT TCA AC Basic copy gene 







22R GAG CGA GCT TGA GGT CCT TTA  G Basic copy gene 






Primer Sequence 5' to 3' Genome Position Bp Tm Source NCBI Nucleotide
(°C) Accession Position
TC1F AAC GAG GTG CTT ATG AAA CCG TG HSP70 gene 143 62.7 THIS
STUDY
M73627 109-131
TC1R AGA GGA GCC ATC ACC ATG ATT TC HSP70 gene 62.7 THIS
STUDY
251-229




AY 178 827 86-110





TC5F TTC ACT GAA AAA CTC ACA GCC CTT G Structural 






TC5R CTT TGC GGA TCT TTT TAA GTT CCT C Structural 






TC14F CTT CTT CCA ACA TGA AGA GGG TG MCAR-1 gene 172 62.7 THIS
STUDY
AJ704363 992-1014
TC14 ATC TTC TCA TTC CAT ACC CTC GG MCAR-1 gene 62.7 THIS 1163-1141
R STUDY
Parasite: Ascaris lumbricoides
Primer Sequence 5 ' to 3 ' Genome Position Bp Tm Source NCBI Nucleotide
(°C) Accession Position





ASRB CAG CTA TAG TTA TTC AGA GTC ACC 18S ssrRNA 
gene
61.1 (Loreille et 
al. 2001)
247-224
ASFE GCT GCG TAC GGC ACT GCG AAA Trans-spliced 
mRNA encoded 
protein gene 12










AL2F GTT TTC AGA GGT GCA CAA GTT C rD N A w  18S 





AL2R CTA GAA TTA  CCA CAG TTA TCC ACG rD N A w  18S 
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minutes; (v) extraction and reagent blanks (negative controls) were simultaneously run alongside 
with the detection PCR.
Samples
Species specific samples were required for each parasite either in the form of DNA or a 
preserved specimen (Biosafety Level 1 or 2). DNA samples specific for P. falciparum and T. 
cruzi were commercially obtained from the American Type Culture Collection (ATCC). DNA 
samples for S. haematobium was donated by Dr. Fred Lewis and DNA samples for L. donovani 
and T. brucei were donated by Dr. Marc Ouellette. Due to the nature of the samples received, no 
extraction or purification steps were required for DNA isolation. A preserved worm specimen, 
morphologically identified as A. lumbricoides, was donated by Dr. Don Martin. This specimen 
required extraction and purification of the tissue for DNA isolation.
Ascaris lumbricoides Extraction/Purification
Sample preparation began with a sectioning of the worm tissue into small fragments, 
approximately 1.0 centimetre in length. DNA extraction and purification of the tissue sections 
commenced with a proteinase K (pK) extraction followed by the phenol :chlorofom separation 
and ethanol precipitation purification methods.
PCR Optimization and Detection
To facilitate PCR optimization, a positive control of DNA from each species was 
analyzed via PCR involving a range of annealing temperatures in order to generate an optimal 
annealing temperature for primer and reaction specificity. Further analysis included the use of a 
diluted DNA template in order to test primer sensitivity (up to 10 000-fold) and specificity.
Once parameters had been finalized, a 25.0pL reaction volume for PCR containing lx  PCR 
buffer, ImM magnesium chloride (MgCL), 0.5mM of each dNTP, 0.5 units of Taq Polymerase,
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optimized concentrations of each forward and reverse primer and IO.OjiL of DNA template was 
run to receive the final amplified target of interest. The reactions were carried with the following 
program: initial denaturation of two minutes at 94°C followed by 45 cycles of denaturation, 
primer annealing and primer extension at 94°C for one minute, 60°C for one minute and 72°C for 
two minutes, respectively. Following amplification, PCR products were analyzed by 6% 
polyacrylamide gel electrophoresis (PAGE) using a lOObp molecular marker (2.0pL)
(Fermentas) for size approximation, loaded with 5.0pL of PCR product and 3.0pL of 6X loading 
dye [2.5% xylene cyanol (12.0|iL), 2.5% bromophenol blue (12.0pL), 35% Ficoll (432.OpL) and 
544.OpL of ddH20  and a 15 to 20 minute staining period in ethidium bromide (EtBr) solution 
(1/20 dilution using 5.0pL of EtBr stock solution by STRATAGENE ®) and photographed. 
Sequencing
Sequencing of the PCR products confirmed the identification of the species analyzed. It 
occurred in a reaction of varying cycles (dependent on the intensity of the amplified target) of
denaturation, annealing and extension at 96°C for 30 seconds, 50°C for 15 seconds and 72°C for 
four minutes respectively, employing the ABI Prism® 310 or 3100 Genetic Analysis instrument. 
A gene fragment comparison utilizing the sequence product and the sequenced gene fragment 
and the corresponding published gene was carried out by means of BioEdit Sequence Alignment 
Editor.
Cloning
An alternative technique to confirm the species-specific results of DNA amplification 
was used for the PCR products with incompatible primers for direct sequencing. Cloning of the 
PCR products was employed as a suitable option. DNA amplification of the products that 
required cloning utilized the same cycling parameters as outlined above, however a final
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extension at 72°C for 10 minutes was added to ensure that all PCR products are full length and 3’ 
adenylated. PCR products were cloned using T4 DNA ligase to insert the DNA fragment of 
interest into a pure linear pCR®4-TOPO® vector. The ligated vector was introduced into 
competent Escherichia coli TOP 10 cells and grown overnight on Laria-Bertani (LB) Agar 
containing 5-bromo-4-chloro-3-indolyl-(3-D-galactoside (X-Gal) and isopropyl-(3-D- 
thiogalactopryranoside (IPTG) to identify successful pCR®4-TOPO® insertion. The resulting 
glossy, white colonies were plucked and cultured overnight in LB broth. The isolation and 
purification of the resulting DNA sequence was accomplished with the QIAprep plasmid 
purification system and amplified via PCR with sequence specific primers. Sequencing of PCR 
products occurred in a reaction of 40 cycles of 94°C for 30 seconds, 50°C for 15 seconds and 
72°C for four minutes employing the ABI Prism® 310 or 3100 Genetic Analysis instrument.
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STEP I: PCR-BASED DETECTION AND IDENTIFICATION OF PARASITES 
INVOLVED IN HUMAN DISEASE 
Aim
The aim of this section of study is to design and optimize a PCR-based detection and 







6. Ascaris lumbricoides 
PCR Optimization
PCR parameters for each primer set were previously determined (page 60). Throughout 
this process, a standard primer concentration of 0.20p.M for each primer in the singleplex PCR 
was used. A 1000-fold sensitivity of the DNA template was applied to the reaction.
Results
All positive controls were subjected to PCR using each primer set along with PCR 
negatives (no DNA) to test the quality of the PCR reagents and examine for contamination. The 
resulting PCR products were then electrophoresed on 6% polyacrylamide gel and visualized 
(Figure 9).
Each amplified DNA product corresponded to the expected amplicon size previously 
determined for each primer set and all PCR negatives were devoid of DNA. Sequencing of the
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Figure 9. 6%  PAGE images of individual parasite singleplex PCR results. Image schematics as follows: M 
represents lOObp molecular marker; (a) Plasmodium falciparum: lanes 2,4, 6, 8 represent reaction involving primer 
sets DHFT-TS3/DHFR-TS3, MSA-1D/MSA-1B, MSA-2C/MSA-2B and K1-14-P2/K1-14-P1 respectively; lanes 
3,5, 7, 9 represent corresponding PCR negatives; (b) Schistosoma haematobium: lanes 2 ,4 , 6, 8 represent reaction 
involving primer sets SH2F/SH2R, SH3F/SH3R, SH5F/SH5R and SH6F/SH6R respectively; lanes 3, 5, 7, 9 
represent corresponding PCR negatives; (c) Leishmania donovani: lanes 2, 4, 6, 8 represent reaction involving 
primer sets LD1F/LD1R, LD2F/LD2R, LD3F/LD3R and LD4F/LD4R respectively; lanes 3, 5, 7 ,9  represent 
corresponding PCR negatives; (d) Trypanosoma brucei: lanes 2 ,4 , 6, 8 represent reaction involving primer sets 
TB3F/TB3R, TB7F/TB7R, 21F/21R and 22F/22R respectively; lanes 3, 5, 7, 9 represent corresponding PCR 
negatives; (e) Trypanosoma cruzi: lanes 2, 4, 6, 8 represent reaction involving primer sets TC1F/TC1R, 
TC3F/TC3R, TC5F/TC5R and TC14F/TC14R respectively; lanes 3, 5, 7, 9 represent corresponding PCR negatives; 
(f) Ascaris lumbricoides: lanes 2, 4, 6, 8 represent reaction involving primer sets AL2F/AL2R, AL3F/AL3R, 
ASFB/ASRB and ASFE/ASRE respectively; lanes 3, 5, 7, 9 represent corresponding PCR negatives.
64
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
PCR products followed, employing the parameters previously outlined. A gene fragment 
comparison utilizing the sequenced gene fragment and the corresponding published gene was 
carried out by means of BioEdit Sequence Alignment Editor (Figures 10 to 15). Comparing the 
two sequences, certain polymorphisms were detected, either as base insertions, base deletions or 
base transitions. These have been outlined in Table 2 along with the percent match of the 
experimentally attained sequence to the published gene fragment. Since the electropherogram 
output reads each base according to the intensity of the signal produced, some base transition 
polymorphisms had a second less intense base reading at the same position and these bases have 
also been outlined. With the inclusion of these anomalies in the sequence output, the percent 
match between the experimentally attained sequence and the published sequence is increased. 
Overall, the resultant sequences in each analysis confirmed the identification of each species 
within the amplified PCR products. Only one of the sequences did not produce a species- 
specific identification. This occurred with the SH2F sequence, which identified S. haematobium 
as well as S. intercalatum. Since these two species have very similar gene sequences, the 
experimentally attained sequence was not able to distinguish between the two species. However, 
the primers designed for the analysis are species-specific.
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DHFR-TS GENE TAACAGAATT TTACAAAAAT GTAGACAAAT ATAAAATTAA TTATGAAAAT GATGATGATG
D H F R -T S 3  -----------GAATT TTACAAAAAT GTAGACAAAT ATCAAATTAA TTATGAAAAT GATGATGATG
DHFR-TS GENE ATGAAGAAGA AGATGATTTT G T TT A TT TT A  ATTTTAATAA AGAAAAAGAA GAGAAAAATA
D H F R -T S 3  ATGAAGAAGA AGATGATTTT G T TT A TTTTA  ATTTTAATAA AGAAAAAGAA GAGAAAAATA
DHFR-TS GENE AAAATTCTAT ACATCCAAAT GATTTTCAAA TATATAATAG CTTGAAATAT AAATATCATC
D H F R -T S 3  AAAATTCTAT ACATCCAAAT GATTTTCAAA TATATAATAG CTTGAAATAT AAATATCATC
DHFR-TS GENE CTGAATACCA ATATTTAAAT A TTA TTTA TG  ATATTATGAT GAATGGAAAT AAACAAAGTG
D H F R -T S 3  .CTGAATACCA ATATTTAAAT A TTA TTTA TG  ATATTATGAT GAATGGAAAT AAACAAAGTG
DHFR-TS GENE ATCG A A C G .............................................................................................................................................................................
D H F R -T S 3  A T C G A A -- ...............................................................................................................................................................................
pBRKl-14 CGTGTACCAT ACATCCTACC AACATCGAAA AATACCAAAT ACATCACATC TA TTC TTTCA
• K 1 - 1 4 - P 1 ----------------- GTACCAT ACATCCTACC AACATCGAAA AATACCAAAT ACATCACATC T A TTC TTTC A
pBRKl-14 A TA A TTTTA T ATATTGGAGT T T T T T C T T C A  T T T T T T T T T T  TCTTCGA TAA CGTAAAATCA
* K 1 - 1 4 - P l  A TA A TTTTA T ATATTGGAGT T T T T T C T T C A  T T T T T T T T T T  TCTTCGA TAA CGTAAAATCA
pBRKl-14 AATAAATAAT TAACATAACT AAAGCTATAA CCACTATTGC AACGATAGA...................................
♦ K 1 - 1 4 - P 1  AATAAATAAT TAACATAACT AAAGCTATAA CCACTATTGC AACGATAGA...................................
MSA-1 GENE CAGATGCTAA ATCTTACGCT GATTTAAAAC ATAGAGTTCA AAATTACTTG TTCA CTA TTA
M S A -ID  CAGATGCTAA ATCTTACGCT GATTTAAAAC ATAGAGTTCA AAATTACTTG TTCA CTA TTA
MSA-1 GENE A A G .............................................................................................................................................................................................
M S A -ID  A A G ..............................................................................................................................................................................................
MSA-2 GENE ACAAGCTGAA AATTCTGCTC CAACAGCCGA ACAAACTGAA TCCCCCGAAT TACAATCTGC
M S A -2 C  ACAAGCTGAA AATTCTGCTC CAACAGCCGA ACAAACTGAA TCCCCCGAAT TACAATCTGC
MSA-2 GENE ACCAGAGAAT AAAGGTACAG G A ...........................................................................................................................
M S A -2 C  ACCAGAGAAT AAAGGTACAG G A ............................................................................................................................
Figure 10. Sequence alignment of the four genes analyzed in Plasmodium fa lc iparum . Alignment illustrates the 
published gene fragment sequence followed by the experimentally attained sequence of the corresponding primer. * 
represents the reverse complement of the sequence attained. Sequence polymorphisms highlighted in red.
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SH2 GENE
SH2
CGAAGTTAGG GGTAGTCTCC CTATATAACA TGGCGAGTAA GACCATGTGT AAAG 
CGAAGTTAGG GGTAGTCTCC CTATATAACA TGGCGAGTAA GACCATGTGT AAAG
SH3 GENE A TTTAGTGGT AGTATGATTT TAATTAATAA AATTAATTAA ATGTATATAG GATGCCAGAT
S H 3 F  ATTTAGTGGT AGTATGATTT TAATTAATAA AATTAATTAA ATGTATATAG GATGCCAGAT
SH3 GENE AAGTATGGGT CAGGTTTAGG ...................................................................................................................................
S H 3 F  AAGTATGGGT CAGGTTTAGG ...................................................................................................................................
SH5 GENE CCTGGA TTTG GAATAGTTAG TCATATATGT ATGAGGATAA GTAATAATGA TTC A TC G TTT
S H 5 F  CCTGGATTTG GAATAGTTAG TCATATATGT ATGAGGATAA GTAATAATGA TTC A TC A TTT
SH5 GENE GGGTATTATG GATTGATTTG TGCTATGGCT TCGATAGTTT GCTTAGGAAG TGTAGTTTGA
S H 5 F  GGGTATTATG GATTGATTTG TGCTATGGCT TCGATAGTTT GCTTAGGAAG TGTAGTTTGA
SH5 GENE G C C ...............................................................................................................................................................................................
S H 5 F  G C C ...............................................................................................................................................................................................
SH6 GENE TGCACTTAGA GAGGCACAAC TCTTCCAATC CATAATCAAA AACAATATAT AAATGACAAA
S H 6 F      TCAAA AACAAGATAT AAATGACAAA
* S H 6 R  TGCACTTAGA GAGGCACAAC TCTTCCAATC CATAATCAAA AACAATATAT AAATGACAAA
SH6 GENE TCACACTAGT TTACATATCA TCACACCGAA TACAACAACA CA G A C................................................
S H 6 F  TCACACTAGG TTACATATCA TCACACCGAA TACAACAACA CA G A C................................................
* S H 6 R  TCACACTAGT TTACATATCA CCACACCGAA TACAACAACA CA G A C................................................
Figure 11. Sequence alignment of the four genes analyzed in Schistosoma haematobium. Alignment illustrates 
the published gene fragment sequence followed by the experimentally attained sequence of the corresponding 
primer. * represents the reverse complement of the sequence attained. Sequence polymorphisms highlighted in red.
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LD1 GENE
L D lF
AAGACCATCA AGGATGGCTG CACCGCCGAG GAGTTGTTCC GGGGCGATGG A C TG A C G TA . 
AAGACCATCA AGGATGGCTG CACCGCCGAG GAGCTGTTCC GGGGCGATGG A CTGACGTA.
LD2 GENE GAAGTGGTAC GATGGATGCT A A TCA TTTA T AACACGGGAT CTGCTATTGG CTACCTCGTC
L D 2 F  GAAGTGGTAC GATGGATGCT A A TCA TTTA T AACACGGGAT CTGCTATTGG CTACCTCGTC
LD2 GENE G T C T T .........................................................................................................................................................................................
L D 2 F  G T C T T .........................................................................................................................................................................................
LD3 GENE ACTA TA TTA T CGGTAGTATA ATATCATAAG TATACGGTAT AGATATATGT TAATTGTAGT
L D 3 F  A CTA TA TTA T CGGTAGTATA ATATCATAAG TATACGGTAT AGATATATGT TAATTGTAGT
LD3 GENE
L D 3 F
ATATTGTAGA TCTA TGTTAC AGTGTATAGT CTATGAACTT ACTAGATATA A T TT G TA TTT 
ATATTGTAGA TCTA TGTTAC AGTGTATAGT CTATGAACTT GCTAGATATA A T TT G TA T TT
LD3 GENE GATGCTATAG TGCTACTGAT AGAGTGTACC T A .
L D 3 F  GATGTTATAG TGCTACTGAT AGAGTGTACC T A .
LD4 GENE CGTCAATGGC TTCGTGCTGG ACG GTTTTCC GCGCACCCGC AAGCAGTCGA GGATGATGCA
L D 4 F  CGTCAATGGC TTCNTGCTGG ACG GTTTTCC GCGCACCCGC AAGCAGTCGA GGATGATGCA
LD4 GENE AGATTTGGAG AACGTGAAAG TCGACATTGT GGTCGAGTTG GAGATTTCGG ACAAAGAGCT
L D 4 F  AGATTTGGAG AACGTGAAAG TCGACATTGT GGTCGAGTTG GAGATTTCGA ACAATGAGCT
LD4 GENE
L D 4 F
Figure 12. Sequence alignment of the four genes analyzed in Leishmania donovani. Alignment illustrates the 
published gene fragment sequence followed by the experimentally attained sequence of the corresponding primer. 
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TB3 GENE
TB3F
GGAAGGTGAA T TT G TC TA T T  GGTGTGTACC GCGACGACGC CGACCAGCCT TTTGTGCTGG 
GGAAGGTGAA TTT G TC TA T T  GGTGTGTACC GCGACGACGC CGACCAGCCT TTTGTGCTGG
TB3 GENE AATGTGTGAA ACAAGCCACA TTAGGCACCA ACATGGACTA CGCCCCAGTC ACAGGAATTG
T B 3 F  AATGTGTGAA ACAAGCCACA TTAGGCACCA ACATGGACTA CGCCCCAGTC ACAGGAATTG
TB3 GENE CA A G ............................................................................................................................................................................................
T B 3 F  CA A G ............................................................................................................................................................................................
TB7 GENE CC TTTTG G TA  ATGAGTGAGA AATTCGCAAA TATAAAAGGT GACTCTGCGG TAAACGCCTT
T B 7 F  CC TTTTG G TA  ATGAGTGAGA AATTCGCAAA TATAAAAGGT GACTCTGCGG TAAACGCCTT
TB7 GENE
T B 7 F
CCGTACACTT TGCGAGGGGA AATGGAAAAA 
CCGTACACTT TGCGAGGGGA AATGGAAAAA
21 GENE TAGAAAAATA GGCAACGGAA GAACAAAGTA AGGCGAA-CG ACGGGAGAAC GACGAAAAAA
* 2 1 R  TAGAAAAATA GGCAACGGAA GAACAAAGTA AGGCGAAGCG ACGGGAGAAC GACGAAAAAA
21 GENE ACAAGAGGAT AATAGAC ATG ACGAGGAA.
* 2 1 R  ACAAGAGGAT AATAGACATG ACGAGGAA.
22 GENE CAAGACAACC GAATGCAACA CAGAGTCACC GGAAGACACA AAAGAGCCAG ATCAAACAAC
2 2 F  CAAGACAACC GAATGCAACA CAGAGTCACC GGAAGACACA AAACAGCCAG ATCAAACAAC
22 GENE TCTGTCCAAA A A .
2 2 F TCTGTCCAAA A A .
Figure 13. Sequence alignment of the four genes analyzed in Trypanosoma brucei. Alignment illustrates the 
published gene fragment sequence followed by the experimentally attained sequence of the corresponding primer. 
* represents the reverse complement of the sequence attained. Sequence polymorphisms highlighted in red.
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TCI GENE ACCTCTTACA TG TG TCA TCT TCCGTGCTTA C C T T T T T T T T  CTATCTCTAC CGTAGGAAAT
T C 1 F  ACCTCTTACA TG TG TCA TCT TCCGTGCTTA T C T T G T T T T T  CTATCTCTAC CGTAGGAAAT
TCI GENE CATGGTGATG G C T C ........................................................................................................................................................
T C 1 F  CATGGTGATG G C T C ........................................................................................................................................................
TC3 GENE
T C 3 F
AGTCCACATT TTTCA A C G TT CTATCTAAAA AAGGTGTTCC CGCTGAAAAT CG G CCATTTT 
AGTCCACATT TTTCA A C G TT CTATCTAAAA AAGGTGTTCC CGCTGAAAAT CG G CCATTTT
TC3 GENE
T C 3 F
TC5 GENE
T C 5 F
GCACCATTGA TCCCAACACC GCGGACATTA ACATTCCTGA CG A TCG A T. 
GCACCATTGA TCCCAACACC GCGGACATTA ACA TTCCTGA CGATCGAT.
GACGTACTTG GAGGAACTTA AAAAGATCCG CAAAGA........................................
GACGTACTTG GAGGAACTTA AAAAGATCCG CAAAGA........................................
TC14 GENE CTTTG CTA TC CGCTGCATGT CATGCTGCGC TATGAAATTG AGCGCGATCT GATGGACGGG
T C 1 4 F  CTTTG CTA TC CGCTGCATGT CATGCTGCGC TATGAAATTG AGCGCGATCT GATGGACGGG
TC14 GENE AATATTGAAG CGGAGGAAGT ACCGAGGGTA TGGAATGAGA A G A T .................................................
T C 1 4 F  AATATTGAAG CGGAGGAAGT ACCGAGGGTA TGGAATGAGA A G A T .................................................
Figure 14. Sequence alignment of the four genes analyzed in Trypanosoma cruzi. Alignment illustrates the 
published gene fragment sequence followed by the experimentally attained sequence of the corresponding primer. 
Sequence polymorphisms highlighted in red.
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AL2 GENE AAGTGTGC C G G TTATTAACT GTGCATCTCC CCGATTGATT CTGTCGGCGG T TA TA TG C TT
A L 2 F AAGTGTGCCG GTTATTAACT GTGCATCTCC CCGATTGATT CTGTCGGCGG TTA TA TG C TT
AL2 GENE ATCTCAAAGG CTA A G C -A TG CATGTCTAAG TTCAAATGGC CTATAAAGGT GAAACCGCGA
A L 2 F ATCTCAAAGG CTAAGCCATG CATGTCTAAG TTCAAATGGC CTATAAAGGT GAAACCGCGA
AL2 GENE ACGGCTCATT ACAACAGCTA TTA TA TA C TT GATCTTGATA TCCTACGTGG ATAACTGTGG
A L 2 F ACGGCTCATT ACAACAGCTA TTA TA TA C TT GATCTTGATA TCCTACGTGG ATAAC TGTGG
AL2 GENE T A A TTC TA G .
A L 2 F T A A TTC TA G .
AL3 GENE A C TC G TTTTT GCACTTACCG ATTGTGGGGA TGATCTCGAT GGTTTAATTA C C CAAGTTTG
A L 3 F A C TC G TTTTT GCACTTACCG ATTGTGGGGA TGATCTCGAT GGTTTAATTA CCCAAGTTTG
AL3 GENE AGGTAATTCC GTGTTTCAGC TCAGTGCTTC T A ......................
A L 3 F AGGTAATTC C GTGTTTCAGC TCAGTGCTTC T A ......................
ASB GENE AATGGCCTAA AAAGGTGAAA CCGCGAACGG CTCATTACAA CAGCTATTAT ATACTTGATC
A SFB AATGGCCTAT AAAGGTGAAA CCGCGAACGG CTCATTACAA CAGCTATTAT ATACTTGATC
ASB GENE TTGAAATCCT ACGTGGATAA CTGTGGTAAT TCTAGAGCTA ATACATGCAC CAAAGCTCCG
A SFB TTGATATCCT ACGTGGATAA CTGTGGTAAT TCTAGAGCTA ATACATGCAC CAAAGCTCCG
ASB GENE AATTTTTGAC GAGCGCATCT ATTAGATTAA AACCAATCGG GTTTCGGCCC GTAAATTGGT
A S F B ATTTTCTGAC GAGCGCATCT ATTAGATTAA AACCAATCGG GTTTCGGCCC GTCAATTGGT
ASB GENE GACTCTGAAT AACTATAGCT G A ......................
A S F B GACTCTGAAT AACTATAGCT G A ......................
ASE GENE CTCATCAATG GGAGTGATGA GGCCGGAGCT GATCATGAAA TCCGTTA TTC CTGTCATCAT
A S F E CTCATCAATG GGAGTGATGA GGCCGGAGCT GATCATGAAA TCCGTTA TTC CTGTCATCAT
ASE GENE GGCCGGTCAG TG TTTC CCG T T A T T C .............
A S F E GGCCGGTCAG TG TTTC CCG T T A T T C .............
Figure 15. Sequence alignment of the four genes analyzed in Ascaris lumbricoides. Alignment illustrates the 
published gene fragment sequence followed by the experimentally attained sequence of the corresponding primer. 
Sequence polymorphisms highlighted in red.
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Table 2. Resultant polymorphisms of the published gene fragment sequence compared to the experimentally 
attained gene fragment.
P arasite : Plasmodium falciparum




Sequence Possibility Base Location in 
Gene
DHFR-TS3 99 A to C transition - 823
K1-14-P1 100 - - -
M SA-ID 100 - - -
MSA-2C 100 - - -
P arasite : Schistosoma haematobium




Sequence Possibility Base Location in 
Gene
SH2F 100 - - -
- - -
SH3F 100 - - -
SH5F 99 G to A transition G 702
SH6F 97 T to G transition - 194,218
SH6R 99 T to C transition T 229
P arasite : Leishmania donovani




Sequence Possibility Base Location in 
Gene
LD1F 98 T to C transition - 472
LD2F 100 - - -
LD3F 98 A to G transition - 671
C to T  transition - 695
LD4F 97 Unknown base - 247
G to A transition - 343
A to T  transition - 348
P arasite : Trypanosoma brucei




Sequence Possibility Base Location in 
Gene
TB3F 100 - - -
TB7F 100 - - -
21R 98 G insertion - 2050.1
22F 98 G to C transition G 1219
P arasite : Trypanosoma cruzi




Sequence Possibility Base Location in 
Gene
TC1F 97 C to T transition - 204
T to G transition - 208
TC3F 100 - - -
TC5F 100 - - -
TC14F 100 - - -
P arasite : Ascaris lumbricoides




Sequence Possibility Base Location in 
Gene
AL2F 99 C insertion - 1928.1
AL3F 100 G to C transition - 493
ASFB 98 A to T  transition - 56, 111
ASFE 100
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STEP II: MULTIPLEX PCR-BASED DETECTION AND IDENTIFICATION OF
PARASITES INVOLVED IN HUMAN DISEASE
Aim
The aim of this section of study is to design and optimize a multiplex PCR-based 






5. Trypanosoma cruzi 
PCR Optimization
Since primer optimization and PCR optimization of individual species primer sets was 
carried out, the PCR optimization for this section of study involved multiple trials of PCR runs to 
facilitate a reaction for each species involving the use of multiple amplicons in one reaction. A 
25.0pL reaction volume for PCR containing lx  PCR buffer, ImM magnesium chloride (MgCF),
0.5mM of each dNTP, 0.5 units of Taq Polymerase and lO.OpL of 1000-fold sensitive DNA 
template was run to receive the final amplified target of interest. Primer concentration was 
altered in order to produce an optimal reaction with each amplicon producing a similar intensity 
(Table 3). The reaction parameters followed the original program as stated above (page 60). 
Following amplification, PCR products were analyzed by electrophoresis on 6% polyacrylamide 
gel and photographed.
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Table 3. Primers and concentrations used in the multiplex PCR.
Plasmodium falciparum Schistosoma haematobium Leishmania donovani
Primer Concentration (|iM ) Prim er Concentration (ttM ) Primer Concentration (ttM)
DHFR-TS3 0.12 SH2F 0.18 LD1F 0.20
DHFR-TS2 0.12 SH2R 0.18 LD1R 0.20
KI-14-P2 0.12 SH3F 0.14 LD2F 0.20
K1-14-P1 0.12 SH3R 0.14 LD2R 0.20
MSA-1 0.20 SH5F 0.14 LD3F 0.20
MSA-1 0.20 SH5R 0.14 LD3R 0.20
MSA-2 0.20 SH6F 0.20 LD4F 0.16
MSA-2 0.20 SH6R 0.20 LD4R 0.16
Trypanosoma brucei Trypanosoma cruzi
Primer Concentration (uM ) Prim er Concentration (|iM )
TB3F 0.16 TC1F 0.20
TB3R 0.16 TC1R 0.20
TB7F 0.12 TC3F 0.12
TB7R 0.12 TC3R 0.12
21F 0.16 TC5F 0.20
21R 0.16 TC5R 0.20
22F 0.16 TC14F 0.20
22R 0.16 TC14R 0.20
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Results
All positive controls were subjected to multiplex PCR using each primer set along with 
PCR negatives (no DNA) to test the quality of the PCR reagents and examine for contamination. 
The resultant PCR products were then electrophoresed on 6% polyacrylamide gel for 
visualization (Figure 16).
Each amplified DNA product corresponded to the expected amplicon size previously 
determined for each primer set and all PCR negatives were devoid of DNA. Sequencing of the 
PCR products and gene fragment comparison was previously determined (Step I).
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Figure 16. 6% PAGE images of individual parasite multiplex PCR results. Image schematics as follows: M 
represents lOObp molecular marker; lane 1 represents DNA amplification products via multiplex PCR; lane 2 
represents PCR negative, (a) Plasmodium/a/dparum  (b) Schistosoma haematobium (c) Leishmania donovani (d) 
Trypanosoma brucei (e) Trypanosoma cruzi.
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STEP III: MULTIPLE PARASITE MULTIPLEX PCR-BASED DETECTION AND
IDENTIFICATION OF PARASITES INVOLVED IN HUMAN DISEASE
Aim
The aim of this section of study is to design and optimize a multiple parasite multiplex 







6. Ascaris lumbricoides 
PCR Optimization
PCR optimization for this section of study involved multiple trials of PCR runs to 
facilitate a reaction involving the use of one primer set per parasite (each of differing amplicon 
size) in one reaction. However, due to the interactions of primers within the reaction, an additive 
was included into the reaction to avoid any interactions between primers and relax the DNA 
template. It was found that a 25.0pL reaction volume for PCR containing lx  PCR buffer, ImM 
magnesium chloride (MgCb), 0.5mM of each dNTP, 0.6% of DMSO, 0.5 units of Taq 
Polymerase and 10.0|lL of 1 000-fold sensitive DNA template received the final amplified target 
of interest for each species. However, primer concentration was altered in order to produce an 
optimal reaction with each amplicon producing a similar intensity (Table 4). The reaction 
parameters followed the original program as stated above (page 60). Following amplification,
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Table 4. Primers and concentrations used in the multiple parasite multiplex PCR.
Parasite Primer Concentration (pM ) bp
Plasmodium falciparum DHFR-TS3 0.20 280
DHFR-TS2 0.20
Schistosoma haematobium SH6F 0.16 128
SH6R 0.16
Leishmania donovani LD4F 0.08 218
LD4R 0.08
Trypanosoma brucei 21F 0.08 108
21R 0.08
Trypanosoma cruzi TC3F 0.08 154
TC3R 0.08
Ascaris lumbricoides ASFB 0.08 246
ASRB 0.08
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PCR products were analyzed by electrophoresis on 6% polyacrylamide gel applying the same 
parameters as in Step I.
Results
One species-specific primer set was chosen and included in a multiple parasite multiplex 
PCR. All positive controls were subjected to this multiplex PCR along with a PCR negative (no 
DNA) to test the quality of the PCR reagents and examine for contamination. The resultant PCR 
products were then electrophoresed on 6% polyacrylamide gel for visualization (Figure 17).
Each amplified DNA product corresponded to the expected amplicon size previously 
determined for each primer set and the PCR negative was devoid of DNA. Sequencing of the 
PCR products and gene fragment comparison was previously determined (Step I).
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M 2 4 6
Figure 17. 6% PAGE image of the multiple parasite multiplex PCR results. Image schematics as follows: M 
represents lOObp molecular marker; lane 1 represents amplification of Trypanosoma brucei DNA using primer set 
21F/21R; lane 2 represents amplification of Schistosoma haematobium DNA using primer set SH6F/SH6R; lane 3 
represents amplification of Trypanosoma cruzi DNA using primer set TC3F/TC3R; lane 4 represents amplification 
of Leishmania donovani DNA using primer set LD4F/LD4R; lane 5 represents amplification of Ascaris 
lumbricoides DNA using primer set ASFB/ASRB; lane 6 represents amplification of Plasmodium falciparum DNA 
using primer set DHFR-TS3/SHFR-TS2; lane 7 represents PCR negative.
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DISCUSSION
Modem human infectious diseases are the product of interactions between the biology of 
the infectious agent(s), the environment and human behaviour/biology (Aufderheide et al. 2004). 
If these potential variables do not change, the expression of the disease within a population can 
be expected to remain constant (Aufderheide et al. 2004). Significant alteration in one or more 
of these variables, however, can cause the disease to present itself in a very different fashion 
(Aufderheide et al. 2004). Thus, the development of effective prevention and control measures 
of many infections depends upon knowledge of how the etiological agents survive and are 
transmitted in different environments (Morgan and Thompson 1998). However, the lack or 
inaccurate data currently available may in part be due to variation in diagnostic protocols 
between diagnostic laboratories (Morgan and Thompson 1998). Furthermore, studies need to be 
coupled with newer, more sensitive diagnostic techniques that can provide an accurate picture of 
prevalence in asymptomatic and symptomatic individuals (Morgan and Thompson 1998). PCR 
has provided the basis for the development of a new generation of diagnostics through its 
sensitivity, ease of use and the ability to analyze large numbers of samples simultaneously 
(Morgan and Thompson 1998).
Six parasites involved in the diseases of malaria, schistosomiasis, leishmaniasis, 
trypanosomiasis and ascariasis have been studied. Most of these diseases are tropical diseases; 
however the advent of air transportation has led to the possibility for these diseases to occur in 
geographical areas uncharacteristic of the environment for the proliferation of the diseases. This 
has brought about a number of problems in the medical profession, where clinicians are 
unfamiliar with the signs and symptoms of each condition. The diagnosis has relied heavily on 
numerous tests to confirm the presence or absence of a specific infectious agent. Therefore,
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through the presented research, three sensitive and species-specific detection and identification 
systems have been designed and developed for each parasite involved in disease by utilizing the 
PCR technique and nucleic acid based technology.
The initial investigation involved the design and optimization of a PCR for each parasite 
analyzing four different species-specific gene fragments through the design and optimization of 
oligonucleotide primers unique to each gene investigated (Step I). With this design and 
development, the genus-specific detection and identification of each parasite via PCR has been 
proven by DNA amplification and sequencing of each gene fragment. Secondly, each amplicon 
studied was applied to a multiplex PCR specific for each parasite (Step II). However, due to the 
nature of the oligonucleotide primers designed for the detection and identification of A. 
lumbricoides, a multiplex PCR was not feasible due to extensive primer interaction.
Nevertheless, a multiplex PCR detection and identification system was developed for the 
remaining parasites investigated with DNA product sequencing of each amplicon confirmed in 
Step I. Thirdly, one primer set was chosen to incorporate into a multiple parasite multiplex PCR 
for all six species (Step III). For each species analyzed, we utilized a unique gene fragment with 
a discrete amplicon size in order to visualize by electrophoresis which species would be present. 
In this way, a single test is able to screen for a range o f parasitic diseases to expedite the testing 
process and confirmation of the disease in question in a clinical setting. The sensitivity of these 
studies was an important issue for a number of reasons. Firstly, the greater the sensitivity, the 
less invasive the sampling procedure would have to be from the patient. Secondly, in the process 
of infection, the earlier the presence of parasites in the tissues is detected, the earlier a diagnosis 
of disease would occur. Thirdly, with increased sensitivity, tissues that contain very few
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parasites and had been classified as previously unusable for diagnosis can be analyzed for the 
presence of parasites and thus diagnosed.
Due to the potential risk of contaminating the reaction, each analysis followed a strict 
protocol to ensure minimizing the possibility of cross-contamination and introductory 
contamination from an outside source. The reagent preparation and sample preparation were 
performed in their own separate rooms. All surfaces and instrumentation are cleaned prior to and 
following every use. Each and every step in the analysis has its own dedicated equipment and 
separate hoods. The analysts wear a lab coat, double sleeves and double gloves, and hair net and 
face mask.
Resulting DNA products for each analysis produced thick, high intensity bands due to the 
abundance of DNA generated in the reaction and the fact that a modem DNA template was used 
in each analysis. However, the modem DNA template used in each reaction was of a 1 000-fold 
sensitivity. Since each product visualized by electrophoresis was of high intensity, it can be 
stated that the reaction designed and optimized is highly sensitive. Also, the lack of 
contamination, represented by the absence of amplified DNA in the PCR negative (no DNA 
template added) can thus eliminate the possibility of reagent contamination in the analyses, and 
none of the sequences generated were identified as contamination from any of the laboratory 
personnel or outside source.
The results of this study thus confirm the identification of each parasite as expected with 
the use of modem positive DNA samples in the analyses. Since a few primers were designed 
based on previously published data, the results also verify those previous findings. However, 
during the amplification reaction, some of the primer sets produced a second amplified DNA 
product larger than the targeted amplicon size. Due to the parameters of the PCR, optimization
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for intended degraded DNA analysis, and the fact that modem DNA was used as the template, 
this product could be considered product dimer due to its size as indicated by electrophoresis; 
double the size of the intended product. Nonetheless, this did not interfere with the sequencing 
of each DNA product and may not likely occur if  each system was applied using degraded DNA 
due to the fragmented nature of the DNA and diminished quantity of available DNA.
Each system designed and optimized for the detection of identification of parasites 
involved in human disease can be utilized solely or in conjunction with one another. In the 
individual singleplex PCR, four gene fragments are used for identification of species. The time 
of this reaction would be reduced if  the multiplex PCR for each species were utilized first. A 
multiplex PCR has an advantage over the singleplex PCR in that all four gene targets would be 
simultaneously detected in one reaction. All the amplicons chosen for each multiplex PCR vary 
in size, some greater than others, however, once the PCR products have been electrophoresed, 
the DNA products are easily distinguished. Then again, if  the sample to be analyzed was 
unknown as to which parasite was the cause of the disease represented, use of the multiple 
parasite multiplex PCR first would allow for a single identification to occur. Following this 
identification, proceeding with the species-specific multiplex PCR would verify the initial 
identification of the parasite by the simultaneous amplification of four species-specific gene 
fragments. Each gene fragment could then be analyzed solely for the identification of the 
parasite via DNA sequencing and gene fragment comparison and alignment with a published 
gene.
Each primer set for the PCR system developed was designed to amplify small fragments 
of species-specific DNA likely to remain in archived and archaeological material. Thus, the 
parameters utilized in each reaction follow this objective. Therefore, the initial aim of this study
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was to develop a system of parasite detection applicable for use with modem, archived and 
archaeological material. By analyzing archaeological samples for the detection of parasites 
involved in human disease, we may be able to reconstruct historical data and apply this to further 
our understanding of parasite-host evolution, as well as establishing a foundation of awareness 
for the antiquity o f disease.
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CHAPTER 5: MOLECULAR DETECTION AND IDENTIFICATION OF PARASITES 
INVOLVED IN HUMAN DISEASE: DEGRADED DNA ANALYSES
86
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
DISEASES IN ANTIQUITY
The parasite-human host relationship has evolved as a battle between two organisms, 
with neither of the two a successor. During our relatively short history on Earth, humans have 
acquired an amazing number of parasites, about 300 species of helminth worms and over 70 
species of protozoa (Ashford and Crewe 1998; Cox 2002). One reason for this is that the 
evolution of humans and parasites has run hand in hand (Cox 2002). It has been estimated that 
sometime, about 150 000 years ago, Homo sapiens emerged in eastern Africa (Tishkoff et al.
2001) and spread throughout the world, possibly in several waves (Templeton 2002), until 15 
000 years ago at the end of the Ice Age humans had migrated to and inhabited virtually the whole 
of the face of the Earth, bringing some parasites with them and collecting others on the way (Cox
2002). The role that disease has played in human dispersal and demography has often been 
discussed by historians and geographers and to some extent anthropologists (Taylor et al. 1997). 
The development of settlements and cities facilitated the transmission of infections between 
humans, and the opening up of trade routes resulting in the wider dissemination of parasitic 
infections (Cox 2002). Also, the slave trade, which flourished for three and a half centuries from 
about AD 1500, brought about new parasites to the New World from the Old World (Desportes 
et al. 1985; Cox 2002). The discovery of such information has allowed many researchers to 
construct an evolutionary time line and examine the movement of parasites and the diseases they 
cause throughout history. Thus, we are beginning to learn a lot about the past history of parasitic 
infections from studies of archaeological artefacts, such as the presence of helminth eggs or 
protozoan cysts in coprolites, naturally or artificially preserved bodies (Cox 2002) or written 
records, which brings about a foundation for the investigation of the antiquity of disease.
87
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Early written records of parasitic infections offer insights into understanding the antiquity 
of disease. The first written records of what are almost certainly parasitic infections came from a 
period of Egyptian medicine from 3000 to 400 BC (Cox 2002). Other descriptions of disease 
were found throughout the world as in the writings of physicians in Greece from 800 to 300 BC, 
China from 3000 to 300 BC, India from 2500 to 200 BC, Rome from 700 BC to 400 AD and the 
Arab Empire in the latter part of the first millennium (Cox 2002). However, these described 
conditions may have or may not have been caused by parasites (Cox 2002). New, innovative 
techniques of piecing together the information concerning the antiquity of disease are required. 
Therefore, the molecular detection of infections in ancient remains represents an emerging field 
of research (Zink et al. 2002).
Molecular detection of the agents of disease via PCR has greatly advanced over the years. 
Besides the benefit of a more precise diagnosis in ancient material, it has advanced from isolated 
reports on diagnosis of infectious diseases to much more profound studies on disease frequencies 
in ancient populations and evolutionary aspects of host-pathogen interactions (Zink et al. 2002). 
As a result, theories are emerging as to the origin and transmission of disease (Zink et al. 2002) 
thus contributing to our understanding of the antiquity of disease.
We know that many of the important parasites encountered today not only existed, but 
were widespread, and our early ancestors must have been aware of the presence of the largest 
and most common worms and of some of the diseases caused by parasites (Cox 2002). There 
exists a lot of historical and archaeological evidence of infectious diseases and many have been 
detected in ancient specimens by the successful amplification of the corresponding parasitic or 
pathogenic DNA (Zink et al. 2002). However, there is still a lack of extended studies to gain 
more information about the frequency, transmission and probable evolution of these diseases
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(Zink et al. 2002). The ongoing research in the field of ancient DNA analysis has the potential to 
contribute significantly to a better understanding of host-pathogen or more specifically host- 
parasite interaction, transmission and spread of infectious diseases in historic and modem times 
(Zink et al. 2002). Without a doubt, infectious diseases have changed through pre-historic times 
to present day including changes in virulence and pathogenecity that were associated with the 
progressive development of civilization (Araujo et al. 2003). The subsequent history of human 
parasitology revolves around a number of factors: early descriptions of a particular disease and 
the identification of the parasite causing the disease, the elaboration of the life cycle and the 
establishment of the causal relationship between the parasite and the disease (Cox 2002). 
Presented here are two studies involving degraded DNA analyses that will contribute to the 
understanding of the antiquity of diseases.
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STEP IV: APPLICATION OF A PCR-BASED DETECTION AND IDENTIFICATION 
SYSTEM OF PARASITES INVOLVED IN DISEASE TO DEGRADED SAMPLES 
Aim
The aim of this section of study is to apply the PCR-based detection and identification 
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DEGRADED DNA ANALYSIS I: THE DETECTION AND IDENTIFICATION OF 
PLASMODIUM FALCIPARUM IN CLINICAL ARCHIVAL SAMPLES 
Introduction
Human malaria, caused by four Plasmodium species: P. vivax, P. ovale, P. malariae and 
P. falciparum, has been estimated by the World Health Organization to cause 300-500 clinical 
cases per year, with more than two billion people at risk (Rich and Ayala 2000). Classical 
diagnoses of malaria employed microscopic examination of stained blood smears (Tirasophon et 
al. 1994), with an estimated 60 malaria slides read by one microscopist per day (Jelinek et al. 
1996). However, due to the unsuitability of this application in large epidemiological field trials 
(Jelinek et al. 1996), new and different epidemiological tools that can diagnose malaria on a 
population level, distinguish between present and past infections, and distinguish between 
different strains of parasite are needed (Laserson et al. 1994).
The PCR technique for in vitro DNA amplification has provided information pertaining 
to malaria epidemics and seasonal transmission occurrences, proven highly effective in the 
identification of malarial “mixed” infections, as well as having the capacity to discriminate 
between recrudescences of previous infections and completely new infections, following drug 
treatment (Sallares and Gomzi 2001). Analyses o f archaeological remains via PCR have made 
available important information concerning disease antiquity. Taylor and colleagues (1997) 
successfully amplified and sequenced P. falciparum DNA from a rib bone of an anemic 
individual who had died in 1937. Thus, PCR offers the possibility to compare modem data on 
epidemiology with the situation prevalent in previous times providing direct insights into the 
evolution of pathogens and the interaction with their hosts, which are crucial to understand the 
transmission and spread of particular infectious diseases (Zink et al. 2002).
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Aim
The aim of this study is to apply the designed and optimized PCR-based detection and 
identification system for P. falciparum (Step I) on archived clinical samples.
Materials and Methods 
General Laboratory Procedures
To guard against contamination of the sample with extraneous DNA, several precautions 
were taken: (i) throughout the entire extraction procedure, a face mask and double gloves were 
worn (frequently changed when moving stations); (ii) the sampling and extractions were carried 
out within a room devoid of any modem malaria DNA; (iii) PCR preparation and analysis was 
performed in three separate areas: one area for PCR reagent set-up (hood), one area for PCR 
itself, and one area for PCR analysis; (iv) sterile disposable laboratory instruments were utilized 
whenever possible, as well as positive displacement pipettes and barrier-tipped pipette tips, with 
each area containing its own set of equipment that were not interchanged; (v) all areas prior to 
and following use were thoroughly cleaned using 10% sodium hyperchlorite, ddH20, 70% 
ethanol, and hoods were UV irradiated for at least 30 minutes; (vi) extraction and reagent blanks 
(negative controls) were simultaneously run alongside with the detection PCR; (vii) no positive, 
modem control was mn with the PCR.
Primer and PCR Optimization Design
Four sets of species-specific primers were designed optimized previously (Step I). Each 
set of primers targets a unique gene within the P. falciparum region, and has been designed with 
a suitable amplicon size target as research indicates for degraded DNA analyses. PCR 
optimization had also been previously executed, and parameters are followed as such.
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Samples
Five archived clinical samples of dried seven-year-old blood stored on FT A® GeneCards 
were obtained from individuals from Ghana, Africa. Each sample was analyzed for the presence 
of P. falciparum DNA due to a suspected malarial infection. However, it was unknown as to 
which, if any, were positive for the disease. Thus, the study was done blind. 
Extraction/Purification
Each sample was extracted using the Guanidinium Thiocyanate Extraction procedure 
(Boom et a l, 1990) along with a corresponding extract negative control. Purification was 
executed using two trials of Performa® DTR Gel Filtration Cartridges for optimal purification. 
PCR and Detection
A 25.0j_iL reaction volume was used for the PCR containing IX PCR reaction buffer, 
2mM MgCl2, 0.2mM dNTPs, 0.2|iM of each primer, 0.5 units Taq polymerase, 4.0jiL of sample 
extract and 15.9pL of d d ^O . The PCR began with an initial two-minute denaturation at 94°C, 
followed by 45 cycles of denaturation, annealing, and extension at 94°C for one minute, 60°C 
for one minute and 72°C for two minutes, respectively (no final extension). PCR products 
(6.0pL) were added to 3.0pL of 6X loading dye (produced in laboratory): 12.0pL of 2.5% xylene 
cyanol, 12.0pL 2.5% bromophenol blue, 432.OgL of 35% Ficoll and 544.OpL of ddH20) and 
electrophoresed in a 6.0% (w/v) polyacrylamide gel in 1 X TBE at 120 volts for 50 minutes. 
Amplified DNA was visualized by ethidium bromide staining exposed to ultraviolet light and 
photographed. PCR products were purified and a sequencing reaction of 40 cycles of 96°C for 
30 seconds, 50°C for 15 seconds and 72°C for four minutes was executed. The ABI Prism®
3100 sequencer and analyzer sequenced the products.
93
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Results
All extracts were subjected to PCR using each primer set along with extract and PCR 
negatives (no DNA) to test the quality of the PCR reagents and examine for contamination. The 
resultant PCR products were then electrophoresed on 6% polyacrylamide gel for visualization 
(Figure 18).
Amplified DNA was detected in samples 2, 3, and 4 for three primer sets (Figure 18a,
18c, and 18d) and one primer set amplified DNA from samples 2 and 4 (Figure 18b). Each 
amplified DNA product corresponded to the expected amplicon size previously determined for 
each primer set and all extract and PCR negatives were devoid of DNA. The repetitive nature of 
amplified DNA products in and between the samples provides evidence for the presence of P. 
falciparum DNA within due to multiple gene target analyses via PCR. However, the 
identification of this agent o f disease is conditional upon sequencing.
Sequencing of the PCR products was easily attained due to the specific nature of the 
amplified DNA. A gene fragment comparison utilizing the sequenced gene fragment and the 
corresponding published gene was carried out by means of BioEdit Sequence Alignment Editor 
(Figure 19). The resultant sequences thus confirmed the presence of P. falciparum DNA within 
the three samples however DNA sequencing utilizing primer set K1-14-P primer set was 
unsuccessful (Table 5).
Discussion
The antiquity of malaria has proven difficult to attain due to the many questions 
concerning its history and evolution. Conflicting theories have arisen based on newer studies 
involving molecular evolution. Many researchers have proposed that the spread of malaria in 
Africa coincided with the advent of agriculture (Sallares and Gomzi 2001). However, studies in
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Figure 18. 6% PAGE images of the singleplex PCR results for the five archival samples analyzed. Image 
schematics as follows: M represents the lOObp molecular marker; lanes 4, 6, 8, 10 and 12 represent samples 1 to 5 
respectively; lanes 5 ,1,9, 11 and 13 represent sample 1 to 5 extract negatives respectively; lane 14 represents PCR 
negative, (a) reaction involving primer set DHFR-TS3/DHFR-TS2 (b) reaction involving primer set K1-14-P2/K1- 
14-P1 (c) reaction involving primer set MSA-1D/MSA-1B (d) reaction involving primer set MSA-2C/MSA-2B.
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DHFR-TS GENE AACAGAATTT TACAAAAATG TAGACAAATA TAAAATTAAT TATGAAA  ATGATGATGA
SAM PLE 2  GAATTT TACAWWWATG TAGACRAATA TCARRTTGAT TATGAAATGC ATGMTGATGA
SAM PLE 3  GAATTT TACAAAAATG TAGACRAATA TCARRTTGAT TATGAAATGC ATGMTGATGA
SAM PLE 4   GAATTT TACAWWWATG TAGACRAATA TCARRTTGAT TATGAAATGC ATGMTGATGA
DHFR-TS GENE TGATGAAGAA GAAGATGATT T T G T T T A T T T  TAATTTTAAT AAAGAAAAAG AAGAGAAAAA
SAM PLE 2 TGATGAAGAA GAAGATGATT T TG T TT A TT T  TAATTTTAAT AAAGAMAAMG AAGAGAAAAA
SAM PLE 3 TGATGAAGAA GAAGATGATT T TG T TT A TT T  TAATTTTAAT AAAGAMAAMG AAGAGAAAAA
SAM PLE 4  TGATGAAGAA GAAGATGATT T TG T TT A TT T  TAATTTTAAT AAAGAMAAMG AAGAGAAAAT
DHFR-TS GENE TAAAAATTCT ATACATCCAA A TG A TTTTCA  AATATATAAT AGCTTGAAAT ATAAATATCA
SA M PLE 2 TAAAAATTCT ATACATCCAA A TG A TTTTCA  AATATATAAT AGCTTGAAAT ATAAATATCA
SAM PLE 3 TAAAAATTCT ATACATCCAA A TG A TTTTCA  CATATATAAT AGCTTGAAAT ATAAATATCA
SAM PLE 4  TAAAAATTCT ATACATCCAA A TG A TTTTCA  CATATATAAT AGCTTGAAAT ATAAATATCA
DHFR-TS GENE TCCTGAATAC CAATATTTAA A TA TTA TTTA  TGATATTATG ATGAATGGAA ATAAACAAAG
SAM PLE 2 TCCTGAATAC CACTATTTAA A TR TTA TTTA  TGATATTATG ATGAATGGAA ATAAACAAAG
SAM PLE 3 TCCTGAATAC CAATATTTAA A TR TTA TTTA  TGATATTATG ATGAATGGAA CTAAACAAAG
SAM PLE 4  TCCTGAATAC CAATATTTAA A TR TTA TTTA  TGATATTATG ATGAATGGAA CTAAACAAAG
DHFR-TS GENE T G A TC G ....................................................................................................................................................................................
SAM PLE 2 T G A TC G ......................................................................................................................................................................................
SAM PLE 3 T G A TC G ......................................................................................................................................................................................
( a )  SAM PLE 4  T G A TC G .....................................................................................................................................................................................
MSA-1 GENE CAGATGCTAA A TCTTA C G CT GATTTAAAAC ATAGAGTTCA AAATTACTTG TTCA CTA TTA
SAM PLE 3 CAGATGCTAA A TCTTA C G CT GATTTAAAAC ATAGAGTTCA AAATTACTTG TTC A C TA TTA
SAM PLE 4   TAA ATCTTACGCT GATTTAAAAC ATAGAGTTCA AAATTACTTG TTCA CTA TTA
MSA-1 GENE AAGAACTCA...........................................................................................................................................................................
SAM PLE 3 AAGAACTCA............................................................................................................................................................................
( b )  SAM PLE 4  AAAGACTCA............................................................................................................................................................................
MSA-2 GENE ACAAGCTGAA AATTCTGCTC CAACAGCCGA ACAAACTGAA TCCCCCGAAT TACAATCTGC
SAM PLE 2 ACAAGCTGAA AATTCTGCTC CAACAGCCGA ACAAACTGAA TCCCCCGAAT TACAATCTGC
SAM PLE 3  A AATTCTGCTC CAACAGCCGA ACAAACTGAA TCCCCCGAAT TACAATCTGC
SAM PLE 4   A AATTCTGCTC CAACAGCCGA ACAAACTGAA TCCCCCGAAT TACAATCTGC
MSA-2 GENE ACCAGAGAAT AAAGGTACAG G A ............................................................................................................................
SAM PLE 2 ACCAGAGAAT AAAGGTACAG G A ............................................................................................................................
SA M PLE 3 ACCAGAGAAT AAAGGTACAG G A ...........................................................................................................................
( c )  SAM PLE 4 ACCAGAGAAT AAAGGTACAG G A ............................................................................................................................
Figure 19. Sequence alignments of the three archived Plasmodium falciparum samples and corresponding 
published genes, (a) sequence attained using DHFR-TS3 (b) sequence attained using MSA-1D (c) sequence 
attained using MSA-2C. Sequence polymorphisms highlighted in red, applying the FASTA format: W represents T 
or A, R represents A or G and M represents A or C.
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Table 5. Resultant polymorphisms of the published gene fragment sequence compared to the experimentally 
attained gene fragment for the three archived Plasmodium falciparum samples.
G ene: DHFR-TS
Sample 2 Sample 3 Sample 4





Sequence Base Location 
Possibility in Gene






A t o W  
transition 
A to R 
transition 
A to C 
transition 
A to G 
transition 
TGC insertion
A to M 
transition 
A t o T  
transition
A, A, A  806, 807, 808
A, A, A, A 817 ,825,826, 
1006




A, A, A 842, 894, 897
A, A, A, A 817 ,825 ,826 , 
1006




A, A, A 842, 894, 897
A, A, A 
A, A, A, A 
A, A, A 
A












Sample 2 Sample 3 Sample 4
- 100% sequence match to gene 100% sequence match to gene
G ene: MSA-2
Sample 2 Sample 3 Sample 4
100% sequence match to gene 100% sequence match to gene 100% sequence match to gene
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molecular evolution have demonstrated that P. falciparum diverged from the related chimpanzee 
parasite Plasmodium reichenovi at approximately the same time as their respective host lineages 
diverged between 4 and 10 millions years ago, resulting in co-evolution with hominids (Sallares 
and Gomzi 2001). Furthermore, debate regarding whether population structure of malaria 
followed low levels of genetic polymorphisms or high levels of genetic variation are in question 
(Sallares and Gomzi 2001). The answers to these questions and concerns involving Plasmodium 
species are available through the analyses of archival and archaeological records. Thus, in the 
advent of paleopathology and the PCR technique, the historical time frame of malaria and 
evolutionary portrayal could be found.
Here we have designed an improved method of P. falciparum DNA detection within 
archival samples with increased specificity, through the use of multiple gene target analyses, and 
increased sensitivity, through the use of minimal amounts of DNA template, as to not consume 
the rare amounts of template that may be available for analysis. Due to the nature of the DNA 
template analyzed, fragmented DNA from archival samples, specificity and sensitivity are key 
components. Also, amplicon size and PCR parameters are extremely important, thus each 
parameter has been designed to attain optimal results.
The results have clearly indicated that three of the five samples analyzed contain one 
human-malaria-causing agent, P. falciparum. The reproducibility of this confirmation and the 
reliability and the efficiency in the aforementioned key components has been proven by species 
target DNA amplification and sequencing with no extraneous DNA amplified.
Direct sequencing of PCR-amplified targets from ancient DNA is expected to yield the 
sequence they possessed at the time of death (Salo et al. 1994). As such, we can expect this to be 
true of the archival samples analyzed, at the time of sample allocation. Accordingly, the
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sequencing results attained from the PCR product analyses produced sequences congruent with 
the genes available from literature. However, numerous polymorphisms were observed when 
comparing the sample sequence to the published gene fragment. This was expected as the gene 
sequence used in primer design is a modem variety and may vary with the species variety 
discovered in each sample. Furthermore, due to the nature of the study, done in blind, the results 
have thus confirmed previous findings of P. falciparum infection within the same three samples 
identified by this molecular analysis. The remaining two samples with a non-inclusive result of 
this parasite via molecular analysis were also previously diagnosed as negative.
In conclusion, the findings in the present study suggest a feasibility of use in other 
application of P. falciparum detection. A system such as this, able to amplify small fragments of 
DNA from multiple genes, applicable for archival as well as archaeological analyses, is thus 
important and should find application of malaria confirmation in ancient populations thus 
increasing our knowledge and understanding of its antiquity.
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DEGRADED DNA ANALYSIS II: THE DETECTION AND IDENTIFICATION OF
LEISHMANIA IN ARCHAEOLOGICAL SAMPLES
Introduction
Leishmaniasis is a disease that has scourged through the centuries leaving behind facets 
of its demise. Muco-cutaneous leishmaniasis showed its destruction in pre-Columbian America, 
while cutaneous leishmaniasis revealed a Mesopotamian antiquity (Brothwell and Sandison 
1967). Although these diseases aid in our understanding of leishmaniasis, it is our lack of 
knowledge concerning the antiquity of leishmaniasis and the origins of visceral leishmaniasis 
that still puzzles research.
Human leishmaniasis, commonly known as “Kala-azar” in the Old World and 
“Espundia” in the New World, is a severe chronic disease caused by parasites of the Leishmania 
species (Otero et al. 2000). In the New World agents of the American Leishmaniasis belong the 
genus Leishmania, subgenus Leishmania, complex mexicana (consisting of mexicana, 
amazonensis, and pifanoi) and subgenus Viannia complexes braziliensis and guyanensis. It 
exists as free-living extracellular promastigotes inside their insect vectors, members of the 
phlebotomine sandfly family, and as intracellular amastigotes within the phagolysosome of 
macrophages and reticuloendothelial cells of the infected host (Wilson et al. 1991). 
Differentiation between species may be successfully achieved by microscopy, but this approach 
is labour intensive, has low sensitivity and due to the morphological similarities among the 
species (Singh et al. 1999), an expert microscopist is required or confusion may arise.
Analysis of archaeological remains poses additional problems concerning disease 
identification and species characterization. The recovery of remains with characteristic 
abnormalities representing specific disease is rare and thus a conclusive diagnosis may not be
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favourable. In many instances only skeletal remains are present and therefore hamper the 
diagnosis of infectious disease, which produces characteristic symptoms dermally. To exclude a 
misdiagnosis, molecular research has advanced and designed more efficient means of 
identification via nucleic acids and the PCR technique. This is an attractive option for the 
detection or parasitic protozoa due to its ease of use and the ability to analyze large numbers of 
samples, as well as having the added advantage of being able to detect infectious agents directly 
(Morgan and Thompson 1998).
Aim
The aim of this study is to apply the designed and optimized PCR-based detection and 
identification system for L. donovani (Step I) on archaeological samples.
Materials and Methods 
General Laboratory Procedures
To guard against contamination of the sample with extraneous DNA, several precautions 
were taken: (i) a full-body, hooded Tyvek suit was worn throughout the entire extraction 
procedure, as well as a face mask, goggles and double gloves that were frequently changed when 
moving stations; (ii) at an independent laboratory in a separate location, the sampling and 
extractions were carried out in laminar flow hoods located within a room with no previous 
history of work ever performed on modem or archaeological leishmaniasis; (iii) PCR preparation 
and analysis was performed in three separate areas, one area for PCR reagent set-up (hood), one 
area for PCR itself, and one area for PCR analysis; (iv) sterile disposable laboratory instruments 
were utilized whenever possible, as well as positive displacement pipettes and barrier-tipped 
pipette tips, with each area containing its own set of equipment that were not interchanged; (v) 
all areas prior to and following use were thoroughly cleaned using 10% sodium hyperchlorite,
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ddH20, 70% ethanol, and hoods were UV irradiated for at least one hour; (vi) extraction and 
reagent blanks (negative controls) were simultaneously run alongside with the detection PCR. 
Primer and PCR Optimization Design
Four sets of species-specific primers were designed optimized previously (Step I). Each 
set of primers targets a unique gene within the Leishmania donovani region, and has been 
designed with a suitable amplicon size target as research indicates for degraded DNA analyses. 
PCR optimization had also been previously executed, and parameters are followed as such. 
Samples
The sample collection of four skulls (#3984, #3937, #4156 and #5377 designated samples 
1 to 4 respectively) was excavated by Gustavo Him Paige at the archaeological cemetery of 
Coyo Oriente in the Atacama in Chile. Three skulls (#3984, #3937 and #4156) are 
representatives of the Coyo East, South Group and one skull (#5377) is without group 
assignment. Each skull exhibited pathological lesions in the face, and the characteristics present 
caused consideration for the occurrence of leishmaniasis.
Extraction/Purification
Sample preparation began with steps to eliminate contaminating modem DNA. These 
included UV irradiation, surface removal and pre-wash treatment steps. The samples were then 
prepared by grinding of the muscle tissue attached to the skull surrounding the nasal and orbital 
regions, with a pestle in the microcentrifuge tube to be used for DNA extraction. DNA was 
extracted and purified from this tissue utilizing two methods. The first method employed (E/P 1) 
a modified silica-guanidinium thiocyanate (GuSCN) extraction procedure (Boom et al. 1990) 
followed by purification by means of P-30 spin columns. The second method employed (E/P 2) 
a pK extraction procedure followed by purification via phenol:chlorofom separation and ethanol
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precipitation. Application of P-30 spin columns proceeded by 10% Chelex (Walsh et al. 1991) 
incubation added to the purification of the extract.
PCR and Detection
A 25.0[iL reaction volume for PCR containing IX PCR buffer, 2mM magnesium 
chloride (MgCf), 0.2mM of each dNTP, 0.2jiM of each forward and reverse primer, 1.0 unit of 
Taq Polymerase and 15.0|iL of DNA template. The reactions were conducted in 50 cycles with 
the following program: initial denaturation of two minutes at 94°C followed by 60 cycles of 
denaturation, primer annealing and primer extension at 94°C for one minute, 60°C for 30 seconds 
and 72°C for two minutes respectively. PCR products (5.0pL) were added to 3.0pL of 6X 
loading dye (produced in laboratory): 12.0pL of 2.5% xylene cyanol, 12.0pL 2.5% bromophenol 
blue, 432.OpL of 35% Ficoll and 544.OpL of ddH20 ) and electrophoresed in a 6.0% (w/v) 
polyacrylamide gel in 1 X TBE at 120 volts for 45 minutes. Amplified DNA was visualized by 
ethidium bromide staining, exposed to ultraviolet light and photographed.
Cloning
PCR products were cloned using T4 DNA ligase to insert the DNA fragment of interest 
into a pure linear pUC19 vector. The ligated vector was introduced into competent Escherichia 
coli JM109 cells and grown overnight on LB Agar containing X-Gal and IPTG to identify 
successful pUC19 insertion. The resulting glossy, white colonies were plucked and cultured 
overnight in LB broth. The isolation and purification of the resulting DNA sequence was 
accomplished with the QIAprep plasmid purification system and amplified via PCR with 
sequence specific primers. Sequencing of PCR products occurred in a reaction of 40 cycles of 
96°C for 30 seconds, 50°C for 15 seconds and 72°C for four minutes employing the ABI 
Prism® 3100 Genetic Analysis instrument.
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Results
Preliminary testing of the primer sets used in this experiment yielded positive 
identifications for Leishmania through PCR and sequencing. Therefore, we were confident that 
these amplicons would facilitate a positive identification in the analysis of the archaeological 
samples of the malformations present.
Tissue sections of samples 1 to 3 (E/P 1) were analyzed using the four primer sets, each 
specific for a unique species-specific gene. Resulting amplification produced a l l  6bp fragment 
of the IMP dehydrogenase gene from sample 2 and a 182bp fragment of the kinetoplast 
minicircle from sample 1 and 2 (Figure 20) indicating successful amplification. Secondly, tissue 
sections of all four samples (E/P 2) were analyzed with all four primer sets. Amplification 
resulted in a 112bp fragment of the IMP dehydrogenase gene and 129bp fragment of the amino 
acid permease AAP13LD gene from sample 3 and a 218bp fragment of the adenylate kinase 
gene from sample 1 (Figure 21). Cloning and sequencing of these products confirmed the 
presence of Leishmania DNA (Figure 22). However the sequences differ slightly from the L. 
donovani sequences, both published and experimentally determined, as expected if  these were 
American forms of Leishmania.
Discussion
Historical documentation of Old World visceral leishmaniasis, or Kala-azar, dates back to 
the mid to late 19 century, however, due to similar pathological manifestations it was diagnosed 
as a virulent form of malaria (Cox 2002). It was not until 1900 that L. donovani was 
characterized as the parasite responsible for the disease (Cox 2002). We can therefore assume 
that previous findings of this disease were characterized incorrectly in many historical 
documents. These documents refer to this as a ‘virulent form of malaria’, but are in actuality
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Figure 20. 6% PAGE image of the singleplex PCR results for archaeological samples 1 to 3 (E/P 1). Image 
schematics as follows: M represents lOObp molecular marker; lanes 1 to 5 represents two extracts of samples 1 and 2 
and one extract of sample 3 respectively; lane 6 represents extract negative; lane 7 represents PCR negative, (a) 
reaction involving primer set LD1F/LD1R (b) reaction involving primer set LD3F/LD3R.
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Figure 21. 6% PAGE images of the singleplex PCR results for archaeological samples 1 to 4 (E/P 2). Image 
schematics as follows: M represents lOObp molecular marker; lanes 2 to 5 represents samples 1 to 4 respectively; 
lanes 7 to 9 represents extract negative, purification negative and PCR negative respectively, (a) reaction involving 
primer set LD1F/LD1R (b) reaction involving primer set LD2F/LD2R (c) reaction involving primer set 
LD4F/LD4R.
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LD3 GENE GGAGTAGCCT CAGGACTTTA GGCGGGAGAT ACTATATTAT CGGTAGTATA ATATCATAAG
SAMPLE 1 F  ---------------------- ----------------------------------------------------------------------------- ------------------------- -------------------------
SAMPLE 2 F  ---------------------- ----------------------------------------------------------------------------- ------------------------- -------------------------
L D 3 F        A CTATATTAT CGGTAGTATA ATATCATAAG
LD3 GENE TATACGGTAT AGATATATGT TAATTGTAG T ATATTGTAGA TCTA TGTTAC AGTGTATAGT
SAMPLE 1 F     GTAGT ATATTGTAGA TCTA TGTTAC AGTGTATAGT
SAMPLE 2 F  -------------------------      GTATAGT
L D 3 F  TATAC GGTAT AGATATATGT TAATTGTAGT ATATTGTAGA TCTA TGTTAC AGTGTATAGT
LD3 GENE CTATGAACTT ACTAGATATA A T T T G -T A T - --T T G A T G C T  A T A G T G C -T - ACTGATAGAG
SAM PLE 1 F  CTATGGACTT GCTAGATATA A T T T G -T A T - - -T T G A T G T T  A G A G T G C -T - ACTGATAGAG
SAMPLE 2  F  CTATGAACTT GCTAGATATA A T T T G G T A T - - -T T G A T G T T  A T A G T G C -T - ACTGATAGAG
L D 3 F  CTATGAACTT GCTAGATATA A T T T G -T A T -  --T T G A T G T T  A T A G T G C -T - ACTGATAGAG
LD3 GENE T G -T A C C T A T  C A C TA G T ...............................................................................................................................................
SAM PLE 1 F  T G ....................... ..........................................................................................................................................................................
SAM PLE 2 F  T G - T A C C T A - .................... .................................................................................................................................................
L D 3 F  T G - T A C C T A - .................... .................................................................................................................................................
Figure 22. Sequence alignments of the archaeological samples, the published genes for Leishmania donovani 
and the experimentally attained sequence. Sample sequence polymorphisms highlighted in red and 
experimentally attained sequence polymorphisms highlighted in blue.
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referring to Leishmaniasis. Therefore, to overcome such inconsistencies in historical diagnosis, 
new methods of genetic testing for this disease in archaeological material must be employed.
We have designed an improved method of detection for Leishmania DNA with increased 
sensitivity and specificity for the parasite through the use of multiple gene targets. The 
sensitivity of the assay is made apparent through the use of very little DNA template in the 
amplification reaction, and its ability to amplify the target DNA in differing tissue types. Due to 
the nature of the samples used in the analysis, the specificity of detection has proven to be 
efficient in that the amplified DNA was that of our target species and no extraneous DNA had 
been amplified. As a result, this system has verified the presence of Leishmania from 
archaeological material through PCR, cloning and sequencing, and thus has confirmed the first 
detection of the disease in ancient DNA.
Strict contamination controls have been employed in this analysis. The modem 
optimization of the primers was performed in a different location from the ancient sample 
extraction. The reagent preparation, sample preparation and extractions are performed in their 
own separate rooms in a dedicated clean room with an air-shower entry, its own separate air 
system. Every surface of this clean laboratory is cleaned with bleach once a month and all 
surfaces are cleaned once a week and before and after every use. Each step in the analysis has its 
own dedicated equipment and separate hoods. Environmental checks are performed regularly by 
swabbing the work areas and testing for the presence of DNA via PCR. The analysts wear a full 
body suit, hood, double sleeves and double gloves, hair net, facemask, hood and additional 
booties. No Leishmania DNA has ever been analyzed in the laboratory nor has any ancient 
samples suspected as having Leishmania ever been analyzed. The analysis also included the 
verification for endogenous DNA from mitochondrial DNA amplification. None of the
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sequences generated were identified as contamination from any of the laboratory handlers or 
analysts and the profiles generated were consistent with South American haplotypes. No DNA 
amplification occurred in any of the PCR or extraction controls that were analyzed. The PCR 
products were cloned and sequenced and one primer set was replicated independently in a 
different laboratory.
Consequently, the sensitivity, specificity, and the rapid and reproducible nature of this 
method have proven highly effective in analyzing archaeological material. Verifying the 
presence of this disease in the past, and comparing them to modem day genetic findings of the 
species will provide useful information into the evolution of the species, its pathogenesis, and its 
spread throughout the regions.
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C H A P T E R  6 : S U M M A T IO N  A N D  A P P L IC A T IO N S
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SUMMARY: DEGRADED DNA ANALYSES
In the past century, detection methods of infectious agents of disease have changed from 
morphological identification, to immunological-based detection and finally to nucleic acid-based 
identification systems. Many methods have been used simultaneously for either verification 
purposes, comparison purposes or to assess the feasibility of a larger study. More recently, 
molecular detection of infectious diseases have been studied using larger series including 
specimens with non-specific or even without morphological alterations, suggesting infection 
with that particular disease (Zink et al. 2002). This approach not only offers the possibility of 
analyzing modem data but also allows for the comparison of similar situations prevalent in 
previous times (Zink et al. 2002).
The comparison of modem and ancient species via DNA sequences has become a major 
factor in describing evolutionary processes. However, the evolutionary processes that generated 
modem species and populations are commonly inferred through the analysis of morphological 
and genetic markers, along with studies of abundance and distribution patterns (Willerslev and 
Cooper 2005). Unfortunately, historical data pertaining to parasites and the diseases they cause 
is lacking. A great deal of the historical documentation available may have been based on 
incorrect diagnosis and there is no method to verify the conclusions of the writings.
Furthermore, the analysis of contemporary organisms can provide only indirect evidence of this 
history, and reconstructions remain tentative if  they cannot be checked against the fossil record 
(Willerslev and Cooper 2005). Therefore, in order to attain relevant information on diseases in 
the past, excavation of archaeological remains and pathological analyses are required. Yet, many 
diseases resemble one another in pathologies or the presence of the disease may not be clearly
i l l
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identified in the remains. Thus, the molecular detection and identification of agents of disease 
must occur to verify the presence of disease.
The invention of the PCR was an extraordinary accomplishment that allowed the 
molecular research world to expand its horizons. It made it possible to routinely amplify and 
study even single surviving molecules, allowing the number and range of aDNA studies to 
diversify with methods now providing a means to record genetic changes in real time, at least 
over short geological time-scales (Willerslev and Cooper 2005). More specifically, in the field 
of paleoparasitology, large-scale studies have begun to reveal the true potential of aDNA to 
record the methods and processes of evolution, providing a unique way to test models and 
assumptions commonly used to reconstruct patterns of evolution, population genetics and 
paleoecological change (Willerslev and Cooper 2005). This is true for the parasites themselves, 
as well as accumulating information pertaining to the host; its life and evolution. For example, if 
features unique to a parasite’s life cycle are known, then the finding of that parasite in an ancient 
human body often can be translated into prediction of an aspect of the human’s behaviour such 
as diet, occupational activity or domestication of certain animals (Aufderheide and Rodriguez- 
Martin 1998). Also, documentation of parasitism provides an opportunity to expand cultural or 
ecological understanding of an archaeological population (Aufderheide and Rodriguez-Martin 
1998). Thus, through the comparative analyses of genomes or complete DNA sequences of 
extant parasitic organisms, a new way of studying the evolution of parasites has been introduced 
(Sallares et al. 2004).
The initial aim of this study was to design and optimize a system to detect and identify 
parasites involved in disease. As a result, three independent systems were designed, each of 
optimum sensitivity and specificity. However, a second major direction of my research focused
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on the analysis of medical archived specimens stored in hospitals and museums to study the 
presence of disease and the causative species in older medical cases.
Application of the singleplex PCR to archived and archaeological samples was performed 
in accordance with the many criteria put forth by numerous researchers for authentic aDNA 
analyses. Strict contamination controls had been implemented throughout each step of the 
analysis. No modem DNA had ever come in contact with the degraded samples as each analysis 
was performed in different locations with separate equipment and in full laboratory attire. As a 
result, each analysis has proven successful. The sequence information attained was used to 
identify the causative agent of disease in these older cases, as either species-specific 
identification for P. falciparum or a genus-specific identification for Leishmania. Thus this 
study leads the way for further analyses involving ancient and/or degraded DNA. Since 
methodological design remained constant throughout each system developed, degraded DNA 
analyses involving each of the multiplex PCRs is feasible.
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FUTURE APPLICATIONS
The identification of diseases in antiquity is of utmost importance for a variety of 
reasons. There are numerous questions concerning the evolution of parasites. For example, 
when examining the history of P. falciparum, did this species diverge from related malaria 
parasite of the chimpanzee P. reichenovi approximately four to 10 millions years ago, or does it 
have a more recent origin (Sallares and Gomzi 2001)? There are also questions concerning 
mutation rates and the rate of spread through populations, questions about its controversial early 
history and debate about population structure (Sallares and Gomzi 2001). With T. cruzi, its 
presence does not seem to affect triatomine significantly nor the mammals which have been 
naturally infected, suggesting a balance between species as a result of long periods of adaptation 
(Guhl et al. 1999; Guhl et al. 2000). Then, is human Chagas’ disease purely an accidental 
occurrence and when did the adaptation of triatomines to human habitats occur (Guhl et al. 1999; 
Guhl et al. 2000)? There are also questions concerning the relationship between A. lumbricoides 
and A. suum and whether each represents a different species (Loreille and Bouchet 2003).
Many disciplines have devoted an extended amount of time trying to identify and 
understand the evolution of disease, the distribution of the agent of disease through host, vector 
and geography and the societal impact. Thus a variety of disciplines may benefit from and 
contribute to overcome the obstacles of degraded DNA analysis of parasites involved in disease. 
The implementation of this study would therefore create a new first step in providing the 
methodology which can be used as a reference guide for further examination of infectious 
diseases through collaborative efforts between disciplines of archaeology, geology and 
volcanology, anthropology, paleopathology and paleoparasitology, histology, chemistry, physics, 
molecular biology, genetics, microbiology, botany, zoology and bioinformatics (Cipollaro et al.
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2005). For example, analyzing some diseases that had a significant impact on past human 
populations that seem to unknown to us today or screening remains for ancient pets and 
domesticated or wild animals that can act as zoonotic reservoirs or vectors for human diseases 
(Greenblatt and Spigelman 2003).
The application of this analytical system to unknown samples greatly increases the 
chances of detecting and identifying an agent of disease, since up to six parasites have been 
identified by the multiple parasite multiplex PCR. However, inclusion of other parasites into a 
system such as this is possible with correct optimization techniques. Thus an array of diseases 
may be detected simultaneously in one reaction. This would then decrease the time required for 
identification as well as cutting down on cost. The information attained can be used to identify 
which species caused the past infection in cases where there is more than one parasite that can 
generate the infection. As well, it can be used to study the parasite’s genetic differences between 
the past and modem varieties and identify evolutionary change over time with the parasite. 
Finally, by identifying the presence of the disease, epidemiological spread of the disease and the 
frequency of the disease can be determined with greater accuracy and certainty in the species and 
the varieties. The results from these and future experiments will allow for inferences to be made 
on disease antiquity, distribution, and spread, thus allowing for the creation of an evolutionary 
timeline of the parasite and thus the disease with the potential involvement of disease therapy, 
treatment and eradication.
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